| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | STK26 OBSCN DAPK1 PRKD3 PTK2B KSR1 BUB1 ULK4 MAP3K15 GRK7 MAP3K14 ADCK2 IKBKE PRKD1 ALPK2 | 3.86e-05 | 446 | 197 | 15 | GO:0004674 |
| GeneOntologyBiologicalProcess | organelle assembly | RABEP2 CCP110 TCTN3 MYH3 CENPF OBSCN RABGAP1 DDB1 CEP350 PTK2B BRCA1 ANLN STARD9 ULK4 KIF11 KNL1 CEP162 SYNE1 MYOM3 RNF213 CEP192 SPAG5 DNAAF2 KIF4B TNKS PRKD1 CFAP69 VPS13B EVI5L PCNT | 4.20e-07 | 1138 | 197 | 30 | GO:0070925 |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle process | CCP110 CENPF USP44 BTN2A2 BRCA1 BRCA2 BUB1 ETAA1 KNL1 APC TRIM39 CEP192 TNKS CDC6 MYO16 TP53BP1 | 4.31e-07 | 362 | 197 | 16 | GO:0010948 |
| GeneOntologyBiologicalProcess | intermediate filament cytoskeleton organization | 4.54e-07 | 99 | 197 | 9 | GO:0045104 | |
| GeneOntologyBiologicalProcess | intermediate filament-based process | 4.95e-07 | 100 | 197 | 9 | GO:0045103 | |
| GeneOntologyBiologicalProcess | intermediate filament organization | 5.86e-07 | 75 | 197 | 8 | GO:0045109 | |
| GeneOntologyBiologicalProcess | cell cycle checkpoint signaling | CENPF USP44 BRCA1 BRCA2 BUB1 ETAA1 KNL1 APC TRIM39 CEP192 CDC6 TP53BP1 | 1.25e-06 | 217 | 197 | 12 | GO:0000075 |
| GeneOntologyBiologicalProcess | negative regulation of mitotic cell cycle phase transition | CENPF USP44 BTN2A2 BRCA1 BUB1 ETAA1 KNL1 APC TRIM39 CEP192 CDC6 MYO16 | 1.37e-06 | 219 | 197 | 12 | GO:1901991 |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle phase transition | CENPF USP44 BTN2A2 BRCA1 BRCA2 BUB1 ETAA1 KNL1 APC TRIM39 CEP192 CDC6 MYO16 TP53BP1 | 1.87e-06 | 311 | 197 | 14 | GO:1901988 |
| GeneOntologyBiologicalProcess | mitotic cell cycle process | CENPF DDB1 USP44 BTN2A2 BRCA1 BRCA2 ANLN BUB1 ETAA1 PHIP KIF11 KNL1 KLF11 APC TRIM39 CEP192 SPAG5 KIF20A CCNB3 KIF4B TNKS CDC6 MYO16 PCNT | 2.28e-06 | 854 | 197 | 24 | GO:1903047 |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle | CCP110 CENPF USP44 BTN2A2 BRCA1 BRCA2 BUB1 ETAA1 KNL1 IPO5 APC TRIM39 CEP192 TNKS CDC6 MYO16 TP53BP1 | 2.47e-06 | 464 | 197 | 17 | GO:0045786 |
| GeneOntologyBiologicalProcess | mitotic cell cycle checkpoint signaling | 3.90e-06 | 163 | 197 | 10 | GO:0007093 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle process | CCP110 CENPF DDB1 USP44 BTN2A2 BRCA1 BRCA2 ANLN BUB1 ETAA1 PHIP KIF11 KNL1 KLF11 APC TRIM39 CEP192 SPAG5 KIF20A TNKS CDC6 MYO16 TP53BP1 | 6.37e-06 | 845 | 197 | 23 | GO:0010564 |
| GeneOntologyBiologicalProcess | regulation of mitotic cell cycle phase transition | CENPF DDB1 USP44 BTN2A2 BRCA1 ANLN BUB1 ETAA1 KNL1 KLF11 APC TRIM39 CEP192 CDC6 MYO16 | 7.91e-06 | 402 | 197 | 15 | GO:1901990 |
| GeneOntologyBiologicalProcess | mitotic spindle assembly checkpoint signaling | 8.86e-06 | 51 | 197 | 6 | GO:0007094 | |
| GeneOntologyBiologicalProcess | spindle assembly checkpoint signaling | 8.86e-06 | 51 | 197 | 6 | GO:0071173 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle phase transition | CENPF DDB1 USP44 BTN2A2 BRCA1 BRCA2 ANLN BUB1 ETAA1 KNL1 KLF11 APC TRIM39 CEP192 CDC6 MYO16 TP53BP1 | 1.00e-05 | 516 | 197 | 17 | GO:1901987 |
| GeneOntologyBiologicalProcess | chromosome segregation | CENPF DDB1 USP44 BRCA1 BRCA2 STARD9 BUB1 KIF11 KNL1 APC CEP192 TEX15 SPAG5 KIF4B TNKS CDC6 | 1.08e-05 | 465 | 197 | 16 | GO:0007059 |
| GeneOntologyBiologicalProcess | negative regulation of mitotic metaphase/anaphase transition | 1.11e-05 | 53 | 197 | 6 | GO:0045841 | |
| GeneOntologyBiologicalProcess | negative regulation of mitotic sister chromatid segregation | 1.11e-05 | 53 | 197 | 6 | GO:0033048 | |
| GeneOntologyBiologicalProcess | negative regulation of sister chromatid segregation | 1.11e-05 | 53 | 197 | 6 | GO:0033046 | |
| GeneOntologyBiologicalProcess | negative regulation of mitotic sister chromatid separation | 1.11e-05 | 53 | 197 | 6 | GO:2000816 | |
| GeneOntologyBiologicalProcess | mitotic spindle checkpoint signaling | 1.11e-05 | 53 | 197 | 6 | GO:0071174 | |
| GeneOntologyBiologicalProcess | negative regulation of metaphase/anaphase transition of cell cycle | 1.38e-05 | 55 | 197 | 6 | GO:1902100 | |
| GeneOntologyBiologicalProcess | negative regulation of chromosome separation | 1.38e-05 | 55 | 197 | 6 | GO:1905819 | |
| GeneOntologyBiologicalProcess | membraneless organelle assembly | CCP110 MYH3 CENPF OBSCN DDB1 BRCA1 ANLN STARD9 KIF11 MYOM3 RNF213 CEP192 SPAG5 KIF4B TNKS PRKD1 | 1.41e-05 | 475 | 197 | 16 | GO:0140694 |
| GeneOntologyBiologicalProcess | spindle checkpoint signaling | 1.70e-05 | 57 | 197 | 6 | GO:0031577 | |
| GeneOntologyBiologicalProcess | negative regulation of chromosome segregation | 1.70e-05 | 57 | 197 | 6 | GO:0051985 | |
| GeneOntologyBiologicalProcess | negative regulation of mitotic cell cycle | CENPF USP44 BTN2A2 BRCA1 BUB1 ETAA1 KNL1 APC TRIM39 CEP192 CDC6 MYO16 | 1.82e-05 | 282 | 197 | 12 | GO:0045930 |
| GeneOntologyBiologicalProcess | regulation of mitotic sister chromatid segregation | 2.29e-05 | 60 | 197 | 6 | GO:0033047 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle phase transition | CENPF DDB1 USP44 BTN2A2 BRCA1 ANLN BUB1 ETAA1 KNL1 KLF11 APC TRIM39 CEP192 CCNB3 CDC6 MYO16 | 3.26e-05 | 509 | 197 | 16 | GO:0044772 |
| GeneOntologyBiologicalProcess | negative regulation of mitotic nuclear division | 3.33e-05 | 64 | 197 | 6 | GO:0045839 | |
| GeneOntologyBiologicalProcess | regulation of mitotic sister chromatid separation | 3.33e-05 | 64 | 197 | 6 | GO:0010965 | |
| GeneOntologyBiologicalProcess | cell cycle phase transition | CENPF DDB1 USP44 BTN2A2 BRCA1 BRCA2 ANLN BUB1 ETAA1 KNL1 KLF11 APC TRIM39 CEP192 CCNB3 CDC6 MYO16 TP53BP1 | 3.44e-05 | 627 | 197 | 18 | GO:0044770 |
| GeneOntologyBiologicalProcess | regulation of mitotic metaphase/anaphase transition | 3.54e-05 | 95 | 197 | 7 | GO:0030071 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle | CENPF DDB1 USP44 BTN2A2 BRCA1 BRCA2 ANLN BUB1 ETAA1 PHIP KIF11 KNL1 KLF11 APC TRIM39 CEP192 SPAG5 KIF20A CCNB3 KIF4B TNKS CDC6 MYO16 PCNT | 3.92e-05 | 1014 | 197 | 24 | GO:0000278 |
| GeneOntologyBiologicalProcess | nuclear chromosome segregation | CENPF DDB1 USP44 BRCA2 BUB1 KIF11 KNL1 APC CEP192 TEX15 SPAG5 KIF4B CDC6 | 4.03e-05 | 356 | 197 | 13 | GO:0098813 |
| GeneOntologyBiologicalProcess | mitotic sister chromatid separation | 4.33e-05 | 67 | 197 | 6 | GO:0051306 | |
| GeneOntologyBiologicalProcess | regulation of metaphase/anaphase transition of cell cycle | 4.33e-05 | 98 | 197 | 7 | GO:1902099 | |
| GeneOntologyBiologicalProcess | metaphase/anaphase transition of mitotic cell cycle | 4.93e-05 | 100 | 197 | 7 | GO:0007091 | |
| GeneOntologyBiologicalProcess | regulation of mitotic cell cycle | CENPF DDB1 USP44 BTN2A2 BRCA1 BRCA2 ANLN BUB1 ETAA1 PHIP KNL1 KLF11 APC TRIM39 CEP192 CDC6 MYO16 | 5.94e-05 | 594 | 197 | 17 | GO:0007346 |
| GeneOntologyBiologicalProcess | metaphase/anaphase transition of cell cycle | 5.96e-05 | 103 | 197 | 7 | GO:0044784 | |
| GeneOntologyBiologicalProcess | DNA methylation-dependent constitutive heterochromatin formation | 6.06e-05 | 44 | 197 | 5 | GO:0006346 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | CCP110 KIZ DDB1 CEP350 BRCA1 BRCA2 STARD9 ULK4 KIF11 APC CEP192 SPAG5 KIF20A DNAAF2 AKAP9 KIF4B TNKS CFAP69 PCNT | 6.44e-05 | 720 | 197 | 19 | GO:0000226 |
| GeneOntologyBiologicalProcess | regulation of cell cycle | CCP110 CENPF DDB1 USP44 BTN2A2 BRCA1 BRCA2 ANLN BUB1 ETAA1 PHIP KIF11 KNL1 IPO5 TBX3 KLF11 APC TRIM39 CEP192 SPAG5 KIF20A DDIAS CCNB3 TNKS CDC6 MYO16 TP53BP1 | 6.57e-05 | 1256 | 197 | 27 | GO:0051726 |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | RABEP2 CCP110 RABGAP1 PTK2B BRCA1 ANLN LRFN5 ATF7IP2 ULK4 SYNE1 PPP1R9A APC CLDN3 CEP192 TRIM5 SPAG5 ZNF750 RESF1 AKAP9 SETD5 IKBKE TLN1 PRKD1 CGNL1 EVI5L NCKAP1L | 6.87e-05 | 1189 | 197 | 26 | GO:0044087 |
| GeneOntologyBiologicalProcess | negative regulation of nuclear division | 7.04e-05 | 73 | 197 | 6 | GO:0051784 | |
| GeneOntologyBiologicalProcess | negative regulation of chromosome organization | 7.59e-05 | 107 | 197 | 7 | GO:2001251 | |
| GeneOntologyBiologicalProcess | regulation of sister chromatid segregation | 9.57e-05 | 111 | 197 | 7 | GO:0033045 | |
| GeneOntologyBiologicalProcess | cellular response to hydroperoxide | 9.80e-05 | 10 | 197 | 3 | GO:0071447 | |
| GeneOntologyBiologicalProcess | regulation of chromosome separation | 1.10e-04 | 79 | 197 | 6 | GO:1905818 | |
| GeneOntologyBiologicalProcess | cell cycle process | CCP110 CENPF KIZ DDB1 USP44 BTN2A2 BRCA1 BRCA2 ANLN STARD9 BUB1 ETAA1 PHIP KIF11 KNL1 KLF11 APC TRIM39 CEP192 TEX15 SPAG5 KIF20A CCNB3 KIF4B TNKS CDC6 MYO16 TP53BP1 PCNT | 1.10e-04 | 1441 | 197 | 29 | GO:0022402 |
| GeneOntologyBiologicalProcess | regulation of action potential | 1.26e-04 | 81 | 197 | 6 | GO:0098900 | |
| GeneOntologyBiologicalProcess | cell division | CCP110 CENPF USP44 BRCA2 ANLN BUB1 ULK4 KIF11 KNL1 APC DLL1 SPAG5 KIF20A CCNB3 KIF4B TNKS CDC6 HELLS | 1.32e-04 | 697 | 197 | 18 | GO:0051301 |
| GeneOntologyBiologicalProcess | regulation of cell cycle checkpoint | 1.36e-04 | 52 | 197 | 5 | GO:1901976 | |
| GeneOntologyBiologicalProcess | sister chromatid segregation | 1.73e-04 | 254 | 197 | 10 | GO:0000819 | |
| GeneOntologyBiologicalProcess | facultative heterochromatin formation | 1.78e-04 | 55 | 197 | 5 | GO:0140718 | |
| GeneOntologyBiologicalProcess | chromosome separation | 1.99e-04 | 88 | 197 | 6 | GO:0051304 | |
| GeneOntologyBiologicalProcess | mitotic sister chromatid segregation | 2.09e-04 | 212 | 197 | 9 | GO:0000070 | |
| GeneOntologyBiologicalProcess | mitotic nuclear division | CENPF USP44 ANLN BUB1 PHIP KIF11 KNL1 APC CEP192 SPAG5 KIF4B | 2.40e-04 | 316 | 197 | 11 | GO:0140014 |
| GeneOntologyBiologicalProcess | regulation of chromosome organization | 2.50e-04 | 266 | 197 | 10 | GO:0033044 | |
| GeneOntologyBiologicalProcess | homologous chromosome orientation in meiotic metaphase I | 2.71e-04 | 3 | 197 | 2 | GO:0031619 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | TET2 BRPF3 DDB1 GATAD2B BRCA1 BRCA2 BUB1 ATF7IP2 KDM2B KMT2A TEX15 CGGBP1 GLMN RIF1 RESF1 SETD5 NCOA1 HELLS | 2.79e-04 | 741 | 197 | 18 | GO:0006338 |
| GeneOntologyBiologicalProcess | regulation of mitotic nuclear division | 3.08e-04 | 134 | 197 | 7 | GO:0007088 | |
| GeneOntologyBiologicalProcess | spindle organization | 3.14e-04 | 224 | 197 | 9 | GO:0007051 | |
| GeneOntologyBiologicalProcess | cell projection assembly | RABEP2 CCP110 TCTN3 STK26 RABGAP1 CEP350 ANLN ULK4 CEP162 SYNE1 PPP1R9A APC DNAAF2 CFAP69 EVI5L PCNT NCKAP1L | 3.24e-04 | 685 | 197 | 17 | GO:0030031 |
| GeneOntologyBiologicalProcess | chromosome organization | CENPF ZGRF1 USP44 BRCA2 BUB1 ATF7IP2 KIF11 KNL1 APC CEP192 TEX15 SPAG5 RIF1 RESF1 KIF4B TNKS CDC6 | 3.29e-04 | 686 | 197 | 17 | GO:0051276 |
| GeneOntologyBiologicalProcess | epigenetic regulation of gene expression | TET2 DDB1 BRCA1 ATF7IP2 KMT2A TEX15 CGGBP1 GLMN RIF1 RESF1 HELLS | 3.48e-04 | 330 | 197 | 11 | GO:0040029 |
| GeneOntologyBiologicalProcess | bundle of His cell to Purkinje myocyte communication | 3.59e-04 | 15 | 197 | 3 | GO:0086069 | |
| GeneOntologyBiologicalProcess | regulation of chromosome segregation | 3.84e-04 | 139 | 197 | 7 | GO:0051983 | |
| GeneOntologyBiologicalProcess | nuclear division | CENPF DDB1 USP44 BRCA2 ANLN BUB1 PHIP KIF11 KNL1 APC CEP192 TEX15 SPAG5 KIF4B | 4.26e-04 | 512 | 197 | 14 | GO:0000280 |
| GeneOntologyBiologicalProcess | protein localization to centrosome | 4.62e-04 | 38 | 197 | 4 | GO:0071539 | |
| GeneOntologyBiologicalProcess | protein localization to microtubule organizing center | 5.11e-04 | 39 | 197 | 4 | GO:1905508 | |
| GeneOntologyBiologicalProcess | microtubule-based process | CCP110 SPEM3 KIZ ACTR10 DDB1 CEP350 BRCA1 BRCA2 STARD9 ULK4 KIF11 APC COPG2 CEP192 SPAG5 KIF20A DNAAF2 AKAP9 KIF4B TNKS CFAP69 PCNT | 5.12e-04 | 1058 | 197 | 22 | GO:0007017 |
| GeneOntologyBiologicalProcess | regulation of chromatin organization | 5.64e-04 | 40 | 197 | 4 | GO:1902275 | |
| GeneOntologyBiologicalProcess | regulation of heart rate by cardiac conduction | 6.20e-04 | 41 | 197 | 4 | GO:0086091 | |
| GeneOntologyBiologicalProcess | spindle assembly | 6.83e-04 | 153 | 197 | 7 | GO:0051225 | |
| GeneOntologyBiologicalProcess | action potential | 7.18e-04 | 201 | 197 | 8 | GO:0001508 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | RABEP2 CCP110 TCTN3 STK26 RABGAP1 CEP350 ANLN ULK4 CEP162 SYNE1 PPP1R9A APC DNAAF2 CFAP69 EVI5L PCNT | 7.33e-04 | 670 | 197 | 16 | GO:0120031 |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle cell contraction | 7.44e-04 | 43 | 197 | 4 | GO:0086004 | |
| GeneOntologyBiologicalProcess | negative regulation of organelle organization | CCP110 CENPF USP44 BRCA1 BUB1 KNL1 PPP1R9A APC CEP192 TNKS CGNL1 EVI5L | 7.63e-04 | 421 | 197 | 12 | GO:0010639 |
| GeneOntologyBiologicalProcess | cellular anatomical entity morphogenesis | 7.66e-04 | 156 | 197 | 7 | GO:0032989 | |
| GeneOntologyBiologicalProcess | cellular component assembly involved in morphogenesis | 7.66e-04 | 156 | 197 | 7 | GO:0010927 | |
| GeneOntologyBiologicalProcess | regulation of protein kinase C signaling | 8.68e-04 | 20 | 197 | 3 | GO:0090036 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | MYH3 KRT26 OBSCN PTK2B ALDOA DSP KRT34 KRT35 KRT81 KRT83 KRT86 PPP1R9A MYOM3 APC CEP192 AKAP9 KRT75 PRKD1 CGNL1 NCKAP1L | 8.72e-04 | 957 | 197 | 20 | GO:0097435 |
| GeneOntologyBiologicalProcess | meiotic metaphase I homologous chromosome alignment | 8.91e-04 | 5 | 197 | 2 | GO:0043060 | |
| GeneOntologyBiologicalProcess | skin development | 9.58e-04 | 373 | 197 | 11 | GO:0043588 | |
| GeneOntologyBiologicalProcess | heterochromatin formation | 9.90e-04 | 163 | 197 | 7 | GO:0031507 | |
| GeneOntologyBiologicalProcess | chromatin organization | TET2 BRPF3 DDB1 GATAD2B BRCA1 BRCA2 BUB1 ATF7IP2 KDM2B KMT2A TEX15 CGGBP1 GLMN RIF1 RESF1 SETD5 NCOA1 TP53BP1 HELLS | 9.91e-04 | 896 | 197 | 19 | GO:0006325 |
| GeneOntologyBiologicalProcess | response to hydroperoxide | 1.01e-03 | 21 | 197 | 3 | GO:0033194 | |
| GeneOntologyBiologicalProcess | striated muscle contraction | 1.18e-03 | 217 | 197 | 8 | GO:0006941 | |
| GeneOntologyBiologicalProcess | cilium assembly | RABEP2 CCP110 TCTN3 RABGAP1 CEP350 ULK4 CEP162 SYNE1 DNAAF2 CFAP69 EVI5L PCNT | 1.21e-03 | 444 | 197 | 12 | GO:0060271 |
| GeneOntologyBiologicalProcess | organelle fission | CENPF DDB1 USP44 BRCA2 ANLN BUB1 PHIP KIF11 KNL1 APC CEP192 TEX15 SPAG5 KIF4B | 1.22e-03 | 571 | 197 | 14 | GO:0048285 |
| GeneOntologyBiologicalProcess | ciliary basal body organization | 1.33e-03 | 6 | 197 | 2 | GO:0032053 | |
| GeneOntologyBiologicalProcess | meiotic metaphase chromosome alignment | 1.33e-03 | 6 | 197 | 2 | GO:0051311 | |
| GeneOntologyBiologicalProcess | bundle of His cell-Purkinje myocyte adhesion involved in cell communication | 1.33e-03 | 6 | 197 | 2 | GO:0086073 | |
| GeneOntologyBiologicalProcess | regulation of nuclear division | 1.35e-03 | 172 | 197 | 7 | GO:0051783 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 1.40e-03 | 127 | 197 | 6 | GO:0070252 | |
| GeneOntologyCellularComponent | supramolecular fiber | MYH3 KRT26 OBSCN TMEM214 SCN5A ALDOA KIF11 DSP KRT34 KRT35 KRT81 CEP162 KRT83 SYNE1 KRT86 MYOM3 APC ARFGEF2 PPL SPAG5 KIF20A SLC8A2 KRT75 IFFO2 KIF4B PRKD1 PCNT | 1.92e-05 | 1179 | 198 | 27 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | MYH3 KRT26 OBSCN TMEM214 SCN5A ALDOA KIF11 DSP KRT34 KRT35 KRT81 CEP162 KRT83 SYNE1 KRT86 MYOM3 APC ARFGEF2 PPL SPAG5 KIF20A SLC8A2 KRT75 IFFO2 KIF4B PRKD1 PCNT | 2.16e-05 | 1187 | 198 | 27 | GO:0099081 |
| GeneOntologyCellularComponent | microtubule organizing center | RABEP2 CCP110 CENPF KIZ RABGAP1 CEP350 BRCA1 BRCA2 STARD9 RBBP6 CEP162 APC ARFGEF2 CEP192 CCDC77 SPAG5 DNAAF2 RESF1 AKAP9 CCNB3 TNKS PCNT | 6.33e-05 | 919 | 198 | 22 | GO:0005815 |
| GeneOntologyCellularComponent | intermediate filament | 6.41e-05 | 227 | 198 | 10 | GO:0005882 | |
| GeneOntologyCellularComponent | pericentriolar material | 1.34e-04 | 28 | 198 | 4 | GO:0000242 | |
| GeneOntologyCellularComponent | centrosome | RABEP2 CCP110 CENPF KIZ RABGAP1 CEP350 BRCA1 BRCA2 RBBP6 CEP162 APC ARFGEF2 CEP192 CCDC77 SPAG5 AKAP9 CCNB3 TNKS PCNT | 1.39e-04 | 770 | 198 | 19 | GO:0005813 |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | 2.14e-04 | 263 | 198 | 10 | GO:0045111 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KRT26 TMEM214 KIF11 DSP KRT34 KRT35 KRT81 CEP162 KRT83 KRT86 APC ARFGEF2 PPL SPAG5 KIF20A SLC8A2 KRT75 IFFO2 KIF4B PCNT | 3.61e-04 | 899 | 198 | 20 | GO:0099513 |
| GeneOntologyCellularComponent | chromosomal region | CENPF DDB1 GATAD2B BRCA2 BUB1 KNL1 APC SPAG5 RIF1 TNKS TP53BP1 HELLS | 7.11e-04 | 421 | 198 | 12 | GO:0098687 |
| GeneOntologyCellularComponent | anchoring junction | OBSCN ITGA1 ITGB2 PTK2B PTPN12 CADM1 SCN5A KLF11 DSP APC DUOX2 CLDN3 DLL1 PPL AKAP12 TLN1 CTNNA3 RAI14 PRKD1 CGNL1 | 1.00e-03 | 976 | 198 | 20 | GO:0070161 |
| HumanPheno | Perifollicular hyperkeratosis | 9.85e-06 | 4 | 70 | 3 | HP:0007468 | |
| MousePheno | abnormal chromosome number | 7.38e-06 | 86 | 164 | 8 | MP:0004023 | |
| MousePheno | abnormal chromosome morphology | 1.72e-05 | 126 | 164 | 9 | MP:0003702 | |
| Domain | Filament | 8.19e-07 | 73 | 192 | 8 | PF00038 | |
| Domain | IF | 1.12e-06 | 76 | 192 | 8 | IPR001664 | |
| Domain | Filament | 8.30e-06 | 71 | 192 | 7 | SM01391 | |
| Domain | IF | 9.11e-06 | 72 | 192 | 7 | PS00226 | |
| Domain | Intermediate_filament_CS | 4.56e-05 | 63 | 192 | 6 | IPR018039 | |
| Domain | Znf_RING/FYVE/PHD | BRPF3 ZSWIM2 TRIM24 USP44 BRCA1 RNF10 KDM2B KMT2A MARCHF1 RBBP6 RNF213 TRIM39 RNF17 WDR59 TRIM5 | 8.38e-05 | 459 | 192 | 15 | IPR013083 |
| Domain | Keratin_2_head | 9.79e-05 | 24 | 192 | 4 | IPR032444 | |
| Domain | Keratin_2_head | 9.79e-05 | 24 | 192 | 4 | PF16208 | |
| Domain | PACT_coil_coil | 1.05e-04 | 2 | 192 | 2 | PF10495 | |
| Domain | PACT_domain | 1.05e-04 | 2 | 192 | 2 | IPR019528 | |
| Domain | Keratin_II | 1.36e-04 | 26 | 192 | 4 | IPR003054 | |
| Domain | Protein_Kinase_C_mu-related | 3.13e-04 | 3 | 192 | 2 | IPR015727 | |
| Domain | PROTEIN_KINASE_ST | STK26 OBSCN DAPK1 PRKD3 KSR1 BUB1 ULK4 MAP3K15 GRK7 MAP3K14 IKBKE PRKD1 | 3.81e-04 | 362 | 192 | 12 | PS00108 |
| Domain | Kinase-like_dom | STK26 OBSCN DAPK1 PRKD3 PTK2B KSR1 BUB1 ULK4 MAP3K15 GRK7 MAP3K14 ADCK2 IKBKE PRKD1 ALPK2 | 5.00e-04 | 542 | 192 | 15 | IPR011009 |
| Domain | PROTEIN_KINASE_DOM | STK26 OBSCN DAPK1 PRKD3 PTK2B KSR1 BUB1 ULK4 MAP3K15 GRK7 MAP3K14 ADCK2 IKBKE PRKD1 | 5.99e-04 | 493 | 192 | 14 | PS50011 |
| Domain | - | BRPF3 ZSWIM2 TRIM24 USP44 BRCA1 RNF10 KDM2B KMT2A MARCHF1 RBBP6 RNF213 TRIM39 TRIM5 | 7.84e-04 | 449 | 192 | 13 | 3.30.40.10 |
| Domain | Kinesin_motor_CS | 8.14e-04 | 41 | 192 | 4 | IPR019821 | |
| Domain | BROMODOMAIN_2 | 8.14e-04 | 41 | 192 | 4 | PS50014 | |
| Domain | Bromodomain | 8.93e-04 | 42 | 192 | 4 | IPR001487 | |
| Domain | BROMO | 8.93e-04 | 42 | 192 | 4 | SM00297 | |
| Domain | - | 8.93e-04 | 42 | 192 | 4 | 1.20.920.10 | |
| Domain | PROTEIN_KINASE_ATP | STK26 OBSCN DAPK1 PRKD3 PTK2B BUB1 ULK4 MAP3K15 GRK7 MAP3K14 ADCK2 IKBKE PRKD1 | 9.59e-04 | 459 | 192 | 13 | PS00107 |
| Domain | TMEM132D_N | 1.03e-03 | 5 | 192 | 2 | PF15705 | |
| Domain | TMEM132D_C | 1.03e-03 | 5 | 192 | 2 | PF15706 | |
| Domain | TMEM132_M | 1.03e-03 | 5 | 192 | 2 | IPR031437 | |
| Domain | TMEM132_C | 1.03e-03 | 5 | 192 | 2 | IPR031436 | |
| Domain | TMEM132_N | 1.03e-03 | 5 | 192 | 2 | IPR031435 | |
| Domain | TMEM132 | 1.03e-03 | 5 | 192 | 2 | IPR026307 | |
| Domain | TMEM132 | 1.03e-03 | 5 | 192 | 2 | PF16070 | |
| Domain | - | 1.07e-03 | 44 | 192 | 4 | 3.40.850.10 | |
| Domain | Kinesin | 1.07e-03 | 44 | 192 | 4 | PF00225 | |
| Domain | KISc | 1.07e-03 | 44 | 192 | 4 | SM00129 | |
| Domain | KINESIN_MOTOR_1 | 1.07e-03 | 44 | 192 | 4 | PS00411 | |
| Domain | Kinesin_motor_dom | 1.07e-03 | 44 | 192 | 4 | IPR001752 | |
| Domain | KINESIN_MOTOR_2 | 1.07e-03 | 44 | 192 | 4 | PS50067 | |
| Domain | S_TKc | STK26 OBSCN DAPK1 PRKD3 KSR1 BUB1 MAP3K15 GRK7 MAP3K14 IKBKE PRKD1 | 1.26e-03 | 359 | 192 | 11 | SM00220 |
| Domain | PbH1 | 1.53e-03 | 6 | 192 | 2 | SM00710 | |
| Domain | PbH1 | 1.53e-03 | 6 | 192 | 2 | IPR006626 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 3.10e-07 | 87 | 148 | 9 | MM15351 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 8.54e-06 | 129 | 148 | 9 | M27649 | |
| Pathway | REACTOME_KERATINIZATION | 3.35e-05 | 153 | 148 | 9 | MM15343 | |
| Pubmed | TET2 ZNF536 CENPF TRIML2 ZGRF1 RABGAP1 TRIM24 BRCA2 BUB1 ATF7IP2 KDM2B KIF11 KNL1 CASP8AP2 DNAJC13 LCORL DSP APC COPG2 SPAG5 RESF1 N4BP2 RAI14 PCNT | 4.46e-17 | 418 | 201 | 24 | 34709266 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TET2 CCP110 HIVEP2 AFTPH TRIP11 SH3BP4 CEP350 PTK2B KSR1 KCNQ5 ANLN STARD9 RNF10 KMT2A GOLGA4 KIF11 DSP GRK7 CEP162 COBLL1 MAP3K14 APC CEP192 WDR59 RESF1 AKAP9 IKBKE N4BP2 RAI14 CGNL1 | 3.45e-15 | 861 | 201 | 30 | 36931259 |
| Pubmed | TRIP11 ADCY9 DMXL1 SH3BP4 CEP350 BRCA1 GLI3 ALDOA GOLGA4 DNAJC13 CEP162 APC ARFGEF2 RNF213 COPG2 CEP192 PKHD1L1 PPL AKAP12 KIF20A RIF1 IFFO2 RAI14 CGNL1 ANO3 HELLS | 6.97e-13 | 777 | 201 | 26 | 35844135 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | CENPF KIZ ACTR10 STK26 DDB1 CEP350 ANLN BUB1 POP1 KNL1 IPO5 SYNE1 APC CEP192 TRIM5 PPL AKAP12 SPAG5 KIF20A TLN1 SHCBP1 IFFO2 KIF4B RAI14 CDC6 VPS13B TP53BP1 | 7.98e-10 | 1155 | 201 | 27 | 20360068 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | CCP110 ZGRF1 RABGAP1 TRIP11 BRCA2 BUB1 KDM2B KNL1 CASP8AP2 DSP RBBP6 KRT35 APC CEP192 RESF1 N4BP2 CGNL1 TP53BP1 PCNT | 1.84e-09 | 588 | 201 | 19 | 38580884 |
| Pubmed | RABEP2 CENPF DAPK1 TRIP11 TMEM132B DDB1 GATAD2B GPR158 PLCL1 GOLGA4 KIF11 DNAJC13 SYNE1 PPP1R9A HECTD4 APC AKAP12 AKAP9 N4BP2 KIF4B TNKS PRKD1 TP53BP1 PCNT | 2.19e-09 | 963 | 201 | 24 | 28671696 | |
| Pubmed | RABEP2 ADCY9 CEP350 PTPN12 CADM1 CCDC86 GOLGA4 KNL1 PMS1 DNAJC13 DSP CEP162 PPP1R9A RNF213 COPG2 CEP192 CCDC77 ARHGAP5 GLMN RIF1 AKAP9 DUSP16 RAI14 PCNT HELLS | 2.43e-09 | 1049 | 201 | 25 | 27880917 | |
| Pubmed | 5.39e-09 | 5 | 201 | 4 | 38244928 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | AFTPH TRIP11 DDB1 PTPN12 KMT2A PRR14L ALDOA KIF11 KNL1 PMS1 DSP RBBP6 LARS1 COPG2 AKAP12 SPAG5 RIF1 TLN1 RAI14 CGNL1 TP53BP1 PCNT HELLS | 6.06e-09 | 934 | 201 | 23 | 33916271 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | HIVEP2 OBSCN ADCY9 SH3BP4 SCN5A TMEM132A ULK4 BAMBI MED13 SLC35B3 HECTD4 MYOM3 ARFGEF2 CLDN3 CEP192 DLL1 C2CD2 WDR59 SETD5 TLN1 DUSP16 USP40 EVI5L PCNT | 3.03e-08 | 1105 | 201 | 24 | 35748872 |
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 3.61e-08 | 120 | 201 | 9 | 31413325 | |
| Pubmed | 8.16e-08 | 63 | 201 | 7 | 16831889 | ||
| Pubmed | CCP110 ZGRF1 POP1 DSP SYNE1 COBLL1 TEX15 PPIP5K1 RAI14 CGNL1 VPS13B | 1.35e-07 | 234 | 201 | 11 | 36243803 | |
| Pubmed | TRIML2 STK26 DDB1 CEP350 BUB1 ALDOA KNL1 APC NCOA4 SPAG5 CDC6 | 1.90e-07 | 242 | 201 | 11 | 34011540 | |
| Pubmed | 53BP1 loss rescues embryonic lethality but not genomic instability of BRCA1 total knockout mice. | 1.90e-07 | 3 | 201 | 3 | 32139898 | |
| Pubmed | Novel KRT83 and KRT86 mutations associated with monilethrix. | 1.90e-07 | 3 | 201 | 3 | 25557232 | |
| Pubmed | 1.90e-07 | 3 | 201 | 3 | 11466700 | ||
| Pubmed | Structure and site of expression of a murine type II hair keratin. | 1.90e-07 | 3 | 201 | 3 | 1372089 | |
| Pubmed | 1.90e-07 | 3 | 201 | 3 | 1712823 | ||
| Pubmed | MYH3 OBSCN TRIP11 PRKD3 RNF10 ALDOA MED13 IPO5 DSP SYNE1 MYOM3 AKAP12 AKAP9 TLN1 TNKS | 2.39e-07 | 497 | 201 | 15 | 23414517 | |
| Pubmed | CCP110 CEP350 BRCA1 ANLN KMT2A CCDC86 PHIP MED13 KIF11 CEP162 CCDC77 SPAG5 KIF20A TLN1 RAI14 PCNT HELLS | 2.51e-07 | 645 | 201 | 17 | 25281560 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | DDB1 ANLN BUB1 KIF11 KNL1 IPO5 DNAJC13 DSP DOCK8 ARFGEF2 COPG2 RNF17 RIF1 TLN1 PCNT HELLS | 3.28e-07 | 582 | 201 | 16 | 20467437 |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 3.32e-07 | 256 | 201 | 11 | 33397691 | |
| Pubmed | OBSCN ANLN POP1 KIF11 CEP162 APC COPG2 CEP192 CCDC77 NCOA4 TRIM5 AKAP12 SPAG5 ARHGAP5 ZNF750 RESF1 SETD5 CCDC171 VPS13B TP53BP1 PCNT NCKAP1L | 3.76e-07 | 1084 | 201 | 22 | 11544199 | |
| Pubmed | 4.51e-07 | 210 | 201 | 10 | 16565220 | ||
| Pubmed | TET2 TNFRSF25 HIVEP2 TRIP11 CEP350 CADM1 RNF10 ALDOA MED13 IPO5 DSP KRT83 SYNE1 HECTD4 LARS1 APC ARFGEF2 WDR59 TRIM5 ARHGAP5 RAI14 TNKS ZNF292 PCNT | 4.78e-07 | 1285 | 201 | 24 | 35914814 | |
| Pubmed | Characterization of a 300 kbp region of human DNA containing the type II hair keratin gene domain. | 5.17e-07 | 12 | 201 | 4 | 10692104 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | HIVEP2 KIZ OBSCN RABGAP1 SH3BP4 KCNQ5 GPR158 MARCHF1 GOLGA4 DNAJC13 PPP1R9A HECTD4 PSCA RNF213 CEP192 ATP10A C2CD2 SETD5 USP40 RAI14 PRKD1 CSMD1 CFAP69 VPS13B EVI5L PCNT | 5.49e-07 | 1489 | 201 | 26 | 28611215 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | TRIM24 DDB1 GATAD2B BRCA1 ANLN KDM2B KMT2A CCDC86 PHIP PMS1 IPO5 LCORL KIF20A RIF1 ZNF292 HELLS | 5.85e-07 | 608 | 201 | 16 | 36089195 |
| Pubmed | ZNF536 BRPF3 TRIM24 DDB1 ADCY9 GATAD2B KSR1 BRCA1 GLI3 SCN5A PHIP KNL1 ISLR2 TBX3 RBBP6 RNF213 KIF20A RESF1 CCNB3 SETD5 CSMD1 EVI5L | 6.11e-07 | 1116 | 201 | 22 | 31753913 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | AFTPH KIZ ACTR10 DDB1 CEP350 BRCA2 DSP CEP162 APC CEP192 CCDC77 SPAG5 ARHGAP5 GLMN N4BP2 TLN1 IFFO2 CGNL1 PCNT | 6.25e-07 | 853 | 201 | 19 | 28718761 |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | TET2 TRIM24 GATAD2B ANLN KDM2B KIF11 GNPAT LCORL APC RESF1 NCOA1 TNKS ZNF292 | 6.46e-07 | 398 | 201 | 13 | 35016035 |
| Pubmed | 7.57e-07 | 4 | 201 | 3 | 35205366 | ||
| Pubmed | 7.57e-07 | 4 | 201 | 3 | 27494840 | ||
| Pubmed | Tankyrases maintain homeostasis of intestinal epithelium by preventing cell death. | 7.57e-07 | 4 | 201 | 3 | 30260955 | |
| Pubmed | 7.57e-07 | 4 | 201 | 3 | 23333306 | ||
| Pubmed | 53BP1 mediates productive and mutagenic DNA repair through distinct phosphoprotein interactions. | 7.57e-07 | 4 | 201 | 3 | 23727112 | |
| Pubmed | 7.57e-07 | 4 | 201 | 3 | 15797458 | ||
| Pubmed | Characterization of the interactome of the human MutL homologues MLH1, PMS1, and PMS2. | 7.67e-07 | 87 | 201 | 7 | 17148452 | |
| Pubmed | HIVEP2 SH3BP4 CEP350 CASP8AP2 TBX3 DSP RBBP6 SYNE1 COBLL1 APC RIF1 N4BP2 DUSP16 CGNL1 | 1.06e-06 | 486 | 201 | 14 | 20936779 | |
| Pubmed | KCNQ5 STARD9 GLI3 SYNE1 AKAP12 RIF1 RESF1 NCOA1 RAI14 ZNF292 | 1.16e-06 | 233 | 201 | 10 | 37704626 | |
| Pubmed | 1.50e-06 | 96 | 201 | 7 | 23580065 | ||
| Pubmed | CCP110 AFTPH CENPF GATAD2B SH3BP4 PRKD3 PTPN12 ANLN RBBP6 COBLL1 APC RIF1 SHCBP1 TP53BP1 | 1.58e-06 | 503 | 201 | 14 | 16964243 | |
| Pubmed | ACTR10 TMEM214 RABGAP1 TRIP11 DMXL1 SH3BP4 PRKD3 GOLGA4 DNAJC13 ARFGEF2 WDR59 AKAP12 RAI14 VPS13B | 1.62e-06 | 504 | 201 | 14 | 34432599 | |
| Pubmed | Enteroendocrine and tuft cells support Lgr5 stem cells on Paneth cell depletion. | 1.89e-06 | 5 | 201 | 3 | 31843916 | |
| Pubmed | 2.11e-06 | 101 | 201 | 7 | 10997877 | ||
| Pubmed | 2.69e-06 | 149 | 201 | 8 | 25184681 | ||
| Pubmed | 2.97e-06 | 151 | 201 | 8 | 17043677 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | AFTPH GATAD2B ANLN POP1 KDM2B KMT2A CCDC86 MED13 GOLGA4 DNAJC13 DSP RBBP6 ARFGEF2 PPL RIF1 SHCBP1 TP53BP1 | 3.01e-06 | 774 | 201 | 17 | 15302935 |
| Pubmed | MYH3 SCN11A CENPF BRCA1 STARD9 CTAGE1 KMT2A MED13 KIF11 DSP KRT34 SYNE1 PPP1R9A DUOX2 CCDC77 RNF17 C2orf78 PPL KRT75 SETD5 N4BP2 CFAP69 ZNF292 PCNT | 3.54e-06 | 1442 | 201 | 24 | 35575683 | |
| Pubmed | 3.76e-06 | 6 | 201 | 3 | 34259627 | ||
| Pubmed | An MST4-pβ-CateninThr40 Signaling Axis Controls Intestinal Stem Cell and Tumorigenesis. | 3.76e-06 | 6 | 201 | 3 | 34240584 | |
| Pubmed | The Plk1 target Kizuna stabilizes mitotic centrosomes to ensure spindle bipolarity. | 3.76e-06 | 6 | 201 | 3 | 16980960 | |
| Pubmed | 3.76e-06 | 6 | 201 | 3 | 38554279 | ||
| Pubmed | 3.76e-06 | 6 | 201 | 3 | 22851319 | ||
| Pubmed | 3.92e-06 | 19 | 201 | 4 | 27234308 | ||
| Pubmed | PERP regulates enamel formation via effects on cell-cell adhesion and gene expression. | 3.92e-06 | 19 | 201 | 4 | 21285247 | |
| Pubmed | AFTPH RABGAP1 TRIP11 ALDOA GOLGA4 DNAJC13 SYNE1 LARS1 ARFGEF2 AKAP12 RAI14 | 5.08e-06 | 339 | 201 | 11 | 37232246 | |
| Pubmed | 5.31e-06 | 116 | 201 | 7 | 30804394 | ||
| Pubmed | CCP110 ZNF536 DDB1 ADCY9 GATAD2B CEP350 ANLN PRR14L GOLGA4 KNL1 APC RNF213 NCOA4 WDR59 GLMN N4BP2 | 6.42e-06 | 733 | 201 | 16 | 34672954 | |
| Pubmed | Integrative genomic approach identifies multiple genes involved in cardiac collagen deposition. | 6.54e-06 | 7 | 201 | 3 | 25217174 | |
| Pubmed | CENPF DDB1 BRCA1 ALDOA KIF11 IPO5 DSP LARS1 ARFGEF2 AKAP12 KIF20A TLN1 TP53BP1 | 6.87e-06 | 494 | 201 | 13 | 26831064 | |
| Pubmed | RABEP2 TRIP11 ANLN GOLGA4 PPP1R9A APC PPL AKAP12 TLN1 TP53BP1 PCNT | 8.95e-06 | 360 | 201 | 11 | 33111431 | |
| Pubmed | CP110 cooperates with two calcium-binding proteins to regulate cytokinesis and genome stability. | 1.04e-05 | 8 | 201 | 3 | 16760425 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | TRIM24 ZNF774 GATAD2B BRCA1 BRCA2 ANLN KMT2A ALDOA CCDC86 PHIP KNL1 PMS1 DSP RBBP6 COPG2 RIF1 TP53BP1 HELLS | 1.22e-05 | 954 | 201 | 18 | 36373674 |
| Pubmed | BRCA1 Haploinsufficiency Is Masked by RNF168-Mediated Chromatin Ubiquitylation. | 1.56e-05 | 9 | 201 | 3 | 30704900 | |
| Pubmed | 1.56e-05 | 9 | 201 | 3 | 23657012 | ||
| Pubmed | 1.65e-05 | 250 | 201 | 9 | 33536335 | ||
| Pubmed | Proteomic analysis and identification of cellular interactors of the giant ubiquitin ligase HERC2. | 1.74e-05 | 139 | 201 | 7 | 25476789 | |
| Pubmed | AFTPH TMEM214 TRIM24 DDB1 ADCY9 DMXL1 SH3BP4 POP1 GOLGA4 PMS1 CASP8AP2 DNAJC13 SYNE1 CEP192 CCDC77 AKAP12 AKAP9 N4BP2 TLN1 VPS13B TP53BP1 PCNT HELLS | 1.85e-05 | 1487 | 201 | 23 | 33957083 | |
| Pubmed | HEY1 functions are regulated by its phosphorylation at Ser-68. | 1.96e-05 | 95 | 201 | 6 | 27129302 | |
| Pubmed | Novel interactors and a role for supervillin in early cytokinesis. | 1.99e-05 | 28 | 201 | 4 | 20309963 | |
| Pubmed | ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. | 2.01e-05 | 57 | 201 | 5 | 23788249 | |
| Pubmed | CCP110 DDB1 GATAD2B PTPN12 KMT2A PHIP IPO5 RBBP6 KIF20A N4BP2 TP53BP1 HELLS | 2.06e-05 | 469 | 201 | 12 | 27634302 | |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | TCTN3 DAPK1 KSR1 BAMBI GOLGA4 KIF11 GNPAT SYNE1 PPP1R9A APC CEP192 NCOA4 C2CD2 AKAP12 RAI14 | 2.13e-05 | 719 | 201 | 15 | 35337019 |
| Pubmed | CENPF TRIM24 DDB1 PTPN12 KDM2B CCDC86 KIF11 DNAAF2 RESF1 AKAP9 TP53BP1 | 2.16e-05 | 396 | 201 | 11 | 26687479 | |
| Pubmed | AFTPH CENPF DDB1 ANLN GOLGA4 KIF11 KNL1 KRT83 SPAG5 DNAAF2 RIF1 TP53BP1 | 2.19e-05 | 472 | 201 | 12 | 38943005 | |
| Pubmed | 2.39e-05 | 146 | 201 | 7 | 21399614 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | HIVEP2 PRKD3 USP44 BRCA1 AFP ALDOA KIF11 IPO5 KRT34 KRT35 KRT81 PPP1R9A APC CEP192 WDR59 SHCBP1 TNKS TP53BP1 | 2.44e-05 | 1005 | 201 | 18 | 19615732 |
| Pubmed | TET2 TRIM24 GATAD2B BRCA1 ANLN KMT2A ALDOA KIF11 KNL1 LCORL DOCK8 LARS1 CGGBP1 RESF1 TLN1 NCOA1 TP53BP1 ZNF292 HELLS | 2.45e-05 | 1103 | 201 | 19 | 34189442 | |
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 2.57e-05 | 203 | 201 | 8 | 22083510 | |
| Pubmed | 2.69e-05 | 266 | 201 | 9 | 19380743 | ||
| Pubmed | Proximity interactions among centrosome components identify regulators of centriole duplication. | 2.78e-05 | 101 | 201 | 6 | 24613305 | |
| Pubmed | ZNF536 STARD9 SYNE1 PPP1R9A CEP192 AKAP9 SETD5 TLN1 PPIP5K1 VPS13B PCNT | 2.78e-05 | 407 | 201 | 11 | 12693553 | |
| Pubmed | 2.85e-05 | 268 | 201 | 9 | 33640491 | ||
| Pubmed | TMEM214 RABGAP1 TRIP11 ADCY9 PRR14L GOLGA4 DSP COPG2 C2CD2 AKAP12 TLN1 RAI14 VPS13B | 2.97e-05 | 568 | 201 | 13 | 37774976 | |
| Pubmed | LIS1 regulates CNS lamination by interacting with mNudE, a central component of the centrosome. | 3.03e-05 | 11 | 201 | 3 | 11163258 | |
| Pubmed | 53BP1-RIF1-shieldin counteracts DSB resection through CST- and Polα-dependent fill-in. | 3.03e-05 | 11 | 201 | 3 | 30022158 | |
| Pubmed | 3.03e-05 | 11 | 201 | 3 | 15843429 | ||
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 3.06e-05 | 208 | 201 | 8 | 33230847 | |
| Pubmed | STK26 DAPK1 TRIP11 DDB1 PTK2B KMT2A PLCL1 ALDOA IPO5 DNAJC13 DSP DOCK8 SYNE1 PPP1R9A LARS1 APC ARFGEF2 ARHGAP5 SLC8A2 TLN1 RAI14 CGNL1 | 3.11e-05 | 1431 | 201 | 22 | 37142655 | |
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 17924331 | ||
| Pubmed | Oral contraceptive use and BRCA penetrance: a case-only study. | 3.32e-05 | 2 | 201 | 2 | 19549808 | |
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 34101484 | ||
| Pubmed | Predicting BRCA1 and BRCA2 gene mutation carriers: comparison of PENN II model to previous study. | 3.32e-05 | 2 | 201 | 2 | 20512419 | |
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 22053997 | ||
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 18200524 | ||
| Pubmed | Fertility in women with BRCA mutations: a case-control study. | 3.32e-05 | 2 | 201 | 2 | 19200971 | |
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 28212807 | ||
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 34860830 | ||
| Interaction | KDM1A interactions | TET2 CENPF TRIML2 ZGRF1 RABGAP1 TRIM24 DDB1 CEP350 BRCA1 BRCA2 BUB1 ATF7IP2 RNF10 KDM2B KIF11 KNL1 CASP8AP2 DNAJC13 LCORL DSP KRT35 CEP162 APC COPG2 TRIM39 SPAG5 GLMN ZNF750 RESF1 AKAP9 N4BP2 RAI14 TP53BP1 PCNT | 4.85e-11 | 941 | 199 | 34 | int:KDM1A |
| Interaction | SEPTIN10 interactions | CCP110 CENPF TRIP11 CEP350 BRCA1 ANLN APC CEP192 SPAG5 KIF20A AKAP9 N4BP2 DUSP16 PCNT | 1.69e-10 | 144 | 199 | 14 | int:SEPTIN10 |
| Interaction | SASS6 interactions | RABEP2 CCP110 KIZ TRIP11 CEP350 CEP162 KRT83 APC CEP192 CCDC77 SPAG5 N4BP2 CGNL1 PCNT | 6.35e-10 | 159 | 199 | 14 | int:SASS6 |
| Interaction | KRT38 interactions | CCP110 TRIML2 TRIM24 BRCA2 PRR14L KRT81 KRT83 KRT86 APC SPAG5 KIF20A KRT75 RAI14 PCNT | 1.79e-09 | 172 | 199 | 14 | int:KRT38 |
| Interaction | HDAC1 interactions | RABEP2 TET2 ZNF536 CENPF ZGRF1 RABGAP1 DDB1 GATAD2B BRCA1 BRCA2 ANLN GLI3 BUB1 KDM2B KMT2A GOLGA4 KNL1 IPO5 CASP8AP2 TBX3 KLF11 DNAJC13 APC COPG2 RUNX1T1 SPAG5 KIF20A ZNF750 AKAP9 TLN1 SHCBP1 RAI14 PCNT HELLS | 3.42e-09 | 1108 | 199 | 34 | int:HDAC1 |
| Interaction | KRT8 interactions | CCP110 KRT26 TRIP11 CEP350 ANLN DSP KRT34 KRT35 CEP162 APC CEP192 CCDC77 C2orf78 PPL SPAG5 GLMN AKAP9 KRT75 N4BP2 PCNT | 1.64e-08 | 441 | 199 | 20 | int:KRT8 |
| Interaction | YWHAH interactions | TET2 CCP110 HIVEP2 AFTPH TRIP11 SH3BP4 CEP350 KSR1 KCNQ5 ANLN STARD9 RNF10 KMT2A MAP3K15 GOLGA4 KIF11 DSP CEP162 COBLL1 HECTD4 APC CEP192 RESF1 AKAP9 IKBKE SHCBP1 DUSP16 NCOA1 RAI14 PRKD1 CGNL1 PCNT | 3.86e-08 | 1102 | 199 | 32 | int:YWHAH |
| Interaction | PHF21A interactions | ZNF536 CENPF ZGRF1 RABGAP1 DDB1 BRCA2 BUB1 KDM2B KNL1 CASP8AP2 DNAJC13 DSP APC SPAG5 RESF1 RAI14 PCNT | 5.77e-08 | 343 | 199 | 17 | int:PHF21A |
| Interaction | PFN1 interactions | RABGAP1 TRIM24 TRIP11 CEP350 BRCA1 ANLN GOLGA4 KIF11 DNAJC13 DOCK8 COBLL1 APC CEP192 SPAG5 DNAAF2 ARHGAP5 AKAP9 N4BP2 TP53BP1 PCNT | 1.71e-07 | 509 | 199 | 20 | int:PFN1 |
| Interaction | PRELID2 interactions | 5.02e-07 | 17 | 199 | 5 | int:PRELID2 | |
| Interaction | ANAPC2 interactions | CCP110 ADCY9 CEP350 BRCA2 BUB1 KIF11 APC CEP192 SPAG5 GLMN N4BP2 TP53BP1 PCNT | 6.14e-07 | 234 | 199 | 13 | int:ANAPC2 |
| Interaction | CFAP184 interactions | CCP110 CEP350 BRCA2 BUB1 ETAA1 KIF11 KNL1 SPAG5 KIF20A IFFO2 PCNT | 6.44e-07 | 162 | 199 | 11 | int:CFAP184 |
| Interaction | DUSP16 interactions | TRIP11 CEP350 BRCA2 BUB1 KIF11 KNL1 PMS1 CEP192 SPAG5 N4BP2 DUSP16 PPIP5K1 PCNT | 7.09e-07 | 237 | 199 | 13 | int:DUSP16 |
| Interaction | KRT19 interactions | CEP350 DSP KRT81 CEP162 KRT83 KRT86 PCDHB12 APC CEP192 CCDC77 SPAG5 AKAP9 KRT75 PCNT | 8.71e-07 | 282 | 199 | 14 | int:KRT19 |
| Interaction | PCM1 interactions | CCP110 KIZ CEP350 ETAA1 IPO5 DSP KRT81 CEP162 KRT83 KRT86 CEP192 CCDC77 SPAG5 KIF20A AKAP9 DUSP16 PCNT | 1.57e-06 | 434 | 199 | 17 | int:PCM1 |
| Interaction | YWHAQ interactions | TET2 CCP110 HIVEP2 AFTPH DAPK1 TRIP11 SH3BP4 CEP350 KSR1 KCNQ5 BRCA1 ANLN STARD9 KMT2A ULK4 CEP162 COBLL1 HECTD4 APC ADCK2 CEP192 SLC8A2 TLN1 SHCBP1 DUSP16 NCOA1 RAI14 PRKD1 CGNL1 | 1.82e-06 | 1118 | 199 | 29 | int:YWHAQ |
| Interaction | OFD1 interactions | CEP350 ANLN IPO5 DSP KRT81 CEP162 KRT83 KRT86 LARS1 CEP192 CCDC77 AKAP12 SPAG5 DUSP16 PCNT | 1.99e-06 | 347 | 199 | 15 | int:OFD1 |
| Interaction | YWHAZ interactions | TET2 CCP110 HIVEP2 ITGB2 SH3BP4 KSR1 KCNQ5 BRCA1 ANLN STARD9 KMT2A PRR14L MAP3K15 ALDOA KIF11 KLF11 CEP162 COBLL1 HECTD4 APC CEP192 SPAG5 SLC8A2 AKAP9 SHCBP1 DUSP16 CTNNA3 RAI14 PRKD1 CGNL1 TP53BP1 PCNT | 2.09e-06 | 1319 | 199 | 32 | int:YWHAZ |
| Interaction | RCOR1 interactions | ZNF536 CENPF ZGRF1 RABGAP1 BRCA2 BUB1 KDM2B PHIP KNL1 CASP8AP2 DNAJC13 DSP APC COPG2 ZNF750 RESF1 RAI14 TP53BP1 | 2.13e-06 | 494 | 199 | 18 | int:RCOR1 |
| Interaction | ITPRID2 interactions | 3.03e-06 | 120 | 199 | 9 | int:ITPRID2 | |
| Interaction | NINL interactions | CCP110 KIZ ACTR10 DDB1 CEP350 BRCA1 BRCA2 KIF11 GNPAT DSP CEP162 CEP192 CCDC77 SPAG5 JCHAIN CGNL1 PCNT | 3.23e-06 | 458 | 199 | 17 | int:NINL |
| Interaction | KRT18 interactions | CCP110 CEP350 BRCA1 ANLN IPO5 DSP KRT81 CEP162 APC CEP192 CCDC77 SPAG5 KRT75 CCNB3 N4BP2 PCNT | 4.44e-06 | 419 | 199 | 16 | int:KRT18 |
| Interaction | DTNBP1 interactions | TRIML2 TRIM24 BRCA2 IPO5 SYNE1 ARFGEF2 SPAG5 KRT75 TNKS PCNT | 4.95e-06 | 162 | 199 | 10 | int:DTNBP1 |
| Interaction | CBX3 interactions | BRPF3 TRIM24 DDB1 BRCA1 ANLN KDM2B KMT2A PHIP KNL1 KLF11 RBBP6 COBLL1 TRIM39 KIF20A ZNF750 RIF1 SHCBP1 TP53BP1 ZNF292 HELLS | 6.69e-06 | 646 | 199 | 20 | int:CBX3 |
| Interaction | KRT37 interactions | 6.72e-06 | 100 | 199 | 8 | int:KRT37 | |
| Interaction | DYNLL2 interactions | STK26 THAP10 DDB1 PTPN12 KCNQ5 SPAG5 KIF20A AKAP9 N4BP2 IFFO2 TP53BP1 PCNT | 1.26e-05 | 263 | 199 | 12 | int:DYNLL2 |
| Interaction | DYNLL1 interactions | ACTR10 STK26 THAP10 DDB1 PTPN12 KCNQ5 ANLN ALDOA DSP LARS1 CCDC77 SPAG5 AKAP9 N4BP2 IFFO2 TP53BP1 PCNT | 1.33e-05 | 510 | 199 | 17 | int:DYNLL1 |
| Interaction | AMOT interactions | CCP110 CEP350 KRT34 MYOM3 APC CEP192 CCDC77 SPAG5 RIF1 KRT75 N4BP2 TNKS PCNT | 1.44e-05 | 312 | 199 | 13 | int:AMOT |
| Interaction | AP2B1 interactions | CCP110 AFTPH TRIP11 CEP350 BRCA1 ANLN BUB1 LARS1 APC CEP192 KIF20A AKAP9 N4BP2 PCNT | 2.16e-05 | 373 | 199 | 14 | int:AP2B1 |
| Interaction | KRT25 interactions | 2.28e-05 | 35 | 199 | 5 | int:KRT25 | |
| Interaction | DISC1 interactions | RABGAP1 ITGA1 TRIP11 GATAD2B CEP350 KCNQ5 SYNE1 SPAG5 AKAP9 N4BP2 DUSP16 CTNNA3 TNKS PRKD1 PCNT | 2.51e-05 | 429 | 199 | 15 | int:DISC1 |
| Interaction | KRT79 interactions | 2.51e-05 | 59 | 199 | 6 | int:KRT79 | |
| Interaction | PXN interactions | CCP110 TRIP11 CEP350 PTK2B PTPN12 GOLGA4 APC CEP192 ARHGAP5 AKAP9 N4BP2 TLN1 PCNT | 2.94e-05 | 334 | 199 | 13 | int:PXN |
| Interaction | H3C3 interactions | TRIM24 DDB1 GATAD2B BRCA1 ANLN KDM2B KMT2A CCDC86 PHIP PMS1 IPO5 LCORL KIF20A RIF1 ZNF292 HELLS | 3.47e-05 | 495 | 199 | 16 | int:H3C3 |
| Interaction | CETN1 interactions | 3.66e-05 | 63 | 199 | 6 | int:CETN1 | |
| Interaction | VDR interactions | 3.86e-05 | 127 | 199 | 8 | int:VDR | |
| Interaction | BRCA1 interactions | CENPF OBSCN TRIM24 TRIP11 DDB1 GATAD2B CEP350 BRCA1 BRCA2 ANLN ETAA1 ALDOA KIF11 KNL1 IPO5 DSP MAP3K14 LARS1 ARFGEF2 RUNX1T1 AKAP12 SPAG5 KIF20A RIF1 TLN1 NCOA1 TNKS TP53BP1 | 4.09e-05 | 1249 | 199 | 28 | int:BRCA1 |
| Interaction | CCDC14 interactions | 4.31e-05 | 129 | 199 | 8 | int:CCDC14 | |
| Interaction | CEP78 interactions | 4.67e-05 | 96 | 199 | 7 | int:CEP78 | |
| Interaction | KXD1 interactions | 5.00e-05 | 170 | 199 | 9 | int:KXD1 | |
| Interaction | CCDC171 interactions | 5.12e-05 | 8 | 199 | 3 | int:CCDC171 | |
| Interaction | NIN interactions | KIZ ACTR10 CEP350 BRCA2 ANLN CEP162 APC CEP192 CCDC77 SPAG5 IFFO2 CGNL1 PCNT | 6.16e-05 | 359 | 199 | 13 | int:NIN |
| Interaction | YWHAB interactions | TET2 CCP110 DAPK1 ITGB2 TRIP11 SH3BP4 CEP350 KSR1 KCNQ5 ANLN STARD9 KMT2A IPO5 CEP162 COBLL1 HECTD4 APC CEP192 SLC8A2 AKAP9 SHCBP1 DUSP16 RAI14 CGNL1 | 6.63e-05 | 1014 | 199 | 24 | int:YWHAB |
| Interaction | NDC80 interactions | CCP110 KIZ CEP350 BUB1 KNL1 CEP162 CEP192 CCDC77 SPAG5 AKAP9 KRT75 PCNT | 6.70e-05 | 312 | 199 | 12 | int:NDC80 |
| Interaction | RPGRIP1L interactions | CCP110 CEP350 GOLGA4 CEP162 APC CEP192 SPAG5 N4BP2 RAI14 PCNT | 8.38e-05 | 225 | 199 | 10 | int:RPGRIP1L |
| Interaction | CEP135 interactions | CCP110 CEP350 BRCA2 CEP162 APC CEP192 CCDC77 KIF20A AKAP9 CGNL1 PCNT | 8.66e-05 | 272 | 199 | 11 | int:CEP135 |
| Interaction | FAM131B interactions | 8.81e-05 | 46 | 199 | 5 | int:FAM131B | |
| Interaction | GOLGA1 interactions | 8.83e-05 | 183 | 199 | 9 | int:GOLGA1 | |
| Interaction | NANOG interactions | CENPF TRIM24 DDB1 GATAD2B PTPN12 BRCA1 BRCA2 KDM2B CCDC86 TBX3 RIF1 RESF1 AKAP9 TP53BP1 HELLS | 9.15e-05 | 481 | 199 | 15 | int:NANOG |
| Interaction | USP7 interactions | TET2 CCP110 MYH3 ZNF536 ZGRF1 USP44 BTN2A2 BRCA1 ANLN GLI3 POP1 PHIP ISLR2 TBX3 TRPA1 DSP SYNE1 COBLL1 MYOM3 APC TEX15 PPL IKBKE PPIP5K1 RAI14 CGNL1 CEACAM20 VPS13B | 9.72e-05 | 1313 | 199 | 28 | int:USP7 |
| Interaction | NOLC1 interactions | RABEP2 TRIM24 BRCA1 ANLN PHIP GOLGA4 KIF11 APC RNF213 COPG2 KIF20A AKAP9 | 9.86e-05 | 325 | 199 | 12 | int:NOLC1 |
| Interaction | NAA40 interactions | AFTPH TRIP11 DDB1 PTPN12 KMT2A PRR14L ALDOA KIF11 KNL1 PMS1 DSP RBBP6 LARS1 COPG2 AKAP12 SPAG5 RIF1 TLN1 RAI14 CGNL1 TP53BP1 PCNT HELLS | 1.04e-04 | 978 | 199 | 23 | int:NAA40 |
| Interaction | STIL interactions | 1.17e-04 | 190 | 199 | 9 | int:STIL | |
| Interaction | CDK5RAP2 interactions | 1.17e-04 | 190 | 199 | 9 | int:CDK5RAP2 | |
| Interaction | TNRC6B interactions | KIZ TRIM24 TRIP11 BRCA1 GLI3 PHIP DSP CEP192 SPAG5 KIF20A N4BP2 | 1.19e-04 | 282 | 199 | 11 | int:TNRC6B |
| Interaction | PHLPP1 interactions | CENPF ANLN KIF11 KNL1 DSP APC COPG2 SPAG5 KIF20A GLMN TLN1 RAI14 | 1.24e-04 | 333 | 199 | 12 | int:PHLPP1 |
| Interaction | ATOH1 interactions | 1.41e-04 | 80 | 199 | 6 | int:ATOH1 | |
| Interaction | HERC2 interactions | CCP110 BRCA1 ETAA1 PRR14L KIF11 PMS1 CEP162 HECTD4 COPG2 NCOA4 WDR59 PPL KIF20A AKAP9 TP53BP1 | 1.49e-04 | 503 | 199 | 15 | int:HERC2 |
| Interaction | SOX7 interactions | 1.61e-04 | 82 | 199 | 6 | int:SOX7 | |
| Interaction | NUP43 interactions | TMEM214 CCDC168 DDB1 USP44 BRCA1 BRCA2 KMT2A PHIP KNL1 CASP8AP2 DSP RBBP6 APC SPAG5 RIF1 RESF1 ZNF292 | 1.64e-04 | 625 | 199 | 17 | int:NUP43 |
| Interaction | CALM1 interactions | CCP110 OBSCN DAPK1 TRIM24 DMXL1 KCNQ5 ANLN SCN5A CASP8AP2 TBX3 DNAJC13 KIF20A DNAAF2 RESF1 AKAP9 PRKD1 PCNT | 1.67e-04 | 626 | 199 | 17 | int:CALM1 |
| Interaction | CCT8L2 interactions | 1.71e-04 | 157 | 199 | 8 | int:CCT8L2 | |
| Interaction | CDC16 interactions | RABEP2 CCP110 TRIM24 GATAD2B CEP350 BRCA1 ANLN BUB1 PRR14L TP53BP1 | 1.74e-04 | 246 | 199 | 10 | int:CDC16 |
| Interaction | SFN interactions | TET2 CCP110 AFTPH TRIP11 SH3BP4 CEP350 KSR1 KCNQ5 ANLN KMT2A IPO5 CEP162 COBLL1 APC CEP192 AKAP9 SHCBP1 CGNL1 | 1.82e-04 | 692 | 199 | 18 | int:SFN |
| Interaction | POLH interactions | 1.84e-04 | 84 | 199 | 6 | int:POLH | |
| Interaction | KRT27 interactions | 1.86e-04 | 202 | 199 | 9 | int:KRT27 | |
| Interaction | ASF1A interactions | ZNF536 CENPF TRIM24 GATAD2B BRCA1 BRCA2 ANLN KMT2A CASP8AP2 RIF1 | 1.92e-04 | 249 | 199 | 10 | int:ASF1A |
| Interaction | GAN interactions | 2.18e-04 | 253 | 199 | 10 | int:GAN | |
| Interaction | KRT78 interactions | 2.23e-04 | 87 | 199 | 6 | int:KRT78 | |
| Interaction | KRT3 interactions | 2.38e-04 | 88 | 199 | 6 | int:KRT3 | |
| Interaction | H3C1 interactions | ACTR10 TRIM24 DDB1 GATAD2B ANLN POP1 KDM2B KMT2A PRR14L PHIP KIF11 IPO5 DSP SYNE1 COBLL1 RIF1 CCNB3 SHCBP1 TP53BP1 ZNF292 HELLS | 2.39e-04 | 901 | 199 | 21 | int:H3C1 |
| Interaction | YWHAG interactions | TET2 CCP110 HIVEP2 AFTPH TRIP11 SH3BP4 CEP350 KSR1 KCNQ5 ANLN STARD9 KMT2A DSP CEP162 COBLL1 HECTD4 APC CEP192 AKAP9 N4BP2 SHCBP1 DUSP16 PPIP5K1 RAI14 PRKD1 CGNL1 | 2.54e-04 | 1248 | 199 | 26 | int:YWHAG |
| Interaction | FBXO42 interactions | 2.64e-04 | 259 | 199 | 10 | int:FBXO42 | |
| Interaction | TOP3B interactions | HIVEP2 CENPF OBSCN ADCY9 SH3BP4 SCN5A TMEM132A ULK4 BAMBI MED13 IPO5 PPP1R9A SLC35B3 HECTD4 MYOM3 LARS1 ARFGEF2 CLDN3 CEP192 DLL1 C2CD2 WDR59 SETD5 TLN1 DUSP16 USP40 TP53BP1 EVI5L PCNT | 2.73e-04 | 1470 | 199 | 29 | int:TOP3B |
| Interaction | KRT39 interactions | 2.90e-04 | 59 | 199 | 5 | int:KRT39 | |
| Interaction | KRT72 interactions | 2.90e-04 | 59 | 199 | 5 | int:KRT72 | |
| Interaction | PPP3R2 interactions | 3.02e-04 | 33 | 199 | 4 | int:PPP3R2 | |
| Interaction | EGR2 interactions | 3.06e-04 | 171 | 199 | 8 | int:EGR2 | |
| Interaction | HSPB8 interactions | 3.18e-04 | 172 | 199 | 8 | int:HSPB8 | |
| Interaction | CDC5L interactions | TET2 DDB1 BRCA1 ANLN BUB1 KIF11 KNL1 PMS1 IPO5 DSP DOCK8 RBBP6 SYNE1 COPG2 RNF17 RIF1 AKAP9 TLN1 PCNT HELLS | 3.23e-04 | 855 | 199 | 20 | int:CDC5L |
| Interaction | PML interactions | TET2 TCTN3 TRIML2 TRIM24 GATAD2B BRCA1 ANLN KMT2A ALDOA PHIP KNL1 PMS1 IPO5 CASP8AP2 TBX3 RNF213 KIF20A IKBKE TLN1 TP53BP1 HELLS | 3.81e-04 | 933 | 199 | 21 | int:PML |
| Interaction | SYCE3 interactions | 3.94e-04 | 63 | 199 | 5 | int:SYCE3 | |
| Interaction | KCNA3 interactions | TMEM214 DDB1 ADCY9 KMT2A ALDOA GOLGA4 KIF11 IPO5 DSP RBBP6 COBLL1 LARS1 APC RNF213 COPG2 PPL AKAP12 TLN1 CTNNA3 RAI14 | 4.09e-04 | 871 | 199 | 20 | int:KCNA3 |
| Interaction | HNRNPCL2 interactions | 4.11e-04 | 274 | 199 | 10 | int:HNRNPCL2 | |
| Interaction | HOXB2 interactions | 4.24e-04 | 36 | 199 | 4 | int:HOXB2 | |
| Interaction | LATS1 interactions | TET2 CCP110 MYH3 TRIP11 DDB1 CEP350 KIF11 APC CEP192 CCDC77 RIF1 AKAP9 PCNT | 4.51e-04 | 440 | 199 | 13 | int:LATS1 |
| Interaction | LIMD2 interactions | 4.83e-04 | 16 | 199 | 3 | int:LIMD2 | |
| Interaction | MAPRE3 interactions | 4.84e-04 | 230 | 199 | 9 | int:MAPRE3 | |
| Interaction | TNRC6A interactions | KIZ TRIM24 TRIP11 BRCA1 GLI3 PHIP MED13 CEP192 KIF20A TP53BP1 | 4.87e-04 | 280 | 199 | 10 | int:TNRC6A |
| Interaction | SYNE3 interactions | CCP110 ADCY9 CEP350 KCNQ5 BRCA2 GLI3 ETAA1 APC CEP192 SPAG5 N4BP2 CGNL1 PCNT | 4.91e-04 | 444 | 199 | 13 | int:SYNE3 |
| Interaction | BUB3 interactions | 5.15e-04 | 232 | 199 | 9 | int:BUB3 | |
| Interaction | SVIL interactions | 5.32e-04 | 233 | 199 | 9 | int:SVIL | |
| Interaction | RDX interactions | 5.44e-04 | 284 | 199 | 10 | int:RDX | |
| Interaction | FLNC interactions | 5.48e-04 | 234 | 199 | 9 | int:FLNC | |
| Interaction | MED4 interactions | CCP110 TRIP11 CEP350 ATF7IP2 MED13 KIF11 CEP162 CCDC77 SPAG5 TLN1 RAI14 TP53BP1 PCNT | 5.57e-04 | 450 | 199 | 13 | int:MED4 |
| Interaction | H2BC21 interactions | BRPF3 CENPF OBSCN TRIM24 DDB1 GATAD2B BRCA1 KMT2A CCDC86 PHIP DNAJC13 DUOX2 KIF20A DNAAF2 RIF1 TLN1 ZNF292 | 5.66e-04 | 696 | 199 | 17 | int:H2BC21 |
| Interaction | WDR35 interactions | 5.79e-04 | 39 | 199 | 4 | int:WDR35 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 5.68e-06 | 181 | 128 | 9 | 694 | |
| GeneFamily | Keratins, type II | 3.71e-05 | 27 | 128 | 4 | 609 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 3.11e-04 | 46 | 128 | 4 | 622 | |
| GeneFamily | Ring finger proteins | 7.67e-04 | 275 | 128 | 8 | 58 | |
| GeneFamily | Keratins, type I | 9.98e-04 | 28 | 128 | 3 | 608 | |
| GeneFamily | Zinc fingers MYND-type|A-kinase anchoring proteins | 1.11e-03 | 29 | 128 | 3 | 396 | |
| GeneFamily | EF-hand domain containing|Plakins | 1.35e-03 | 8 | 128 | 2 | 939 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 1.73e-03 | 9 | 128 | 2 | 1203 | |
| GeneFamily | Immunoglobulin like domain containing | 2.53e-03 | 193 | 128 | 6 | 594 | |
| GeneFamily | Zinc fingers CXXC-type | 3.13e-03 | 12 | 128 | 2 | 136 | |
| GeneFamily | PHD finger proteins | 3.83e-03 | 90 | 128 | 4 | 88 | |
| GeneFamily | Endogenous ligands|Minor histocompatibility antigens | 5.63e-03 | 51 | 128 | 3 | 870 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 5.78e-03 | 161 | 128 | 5 | 593 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | HIVEP2 CENPF DAPK1 RABGAP1 TRIM24 ADCY9 CEP350 PTPN12 BRCA1 BRCA2 PHIP MED13 GOLGA4 KIF11 PMS1 DNAJC13 MAP3K14 APC C2CD2 RIF1 AKAP9 NCOA1 TNKS VPS13B TP53BP1 ZNF292 PCNT | 3.71e-10 | 856 | 198 | 27 | M4500 |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | CENPF ZGRF1 BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 IPO5 CASP8AP2 SPAG5 KIF20A DDIAS ZNF750 SHCBP1 KIF4B CDC6 HELLS | 1.88e-09 | 402 | 198 | 18 | MM454 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_PRO_B_CELL | CCP110 CENPF ZGRF1 TRIM24 BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 LCORL SPAG5 KIF20A RIF1 N4BP2 SHCBP1 CDC6 PCNT HELLS | 4.61e-09 | 478 | 198 | 19 | M45785 |
| Coexpression | FEVR_CTNNB1_TARGETS_DN | CCP110 ZGRF1 BRCA1 BRCA2 AFP BUB1 ETAA1 PMS1 CASP8AP2 RWDD3 NCOA4 SPAG5 KIF20A DNAAF2 DDIAS ARHGAP5 SHCBP1 IFFO2 CDC6 HELLS | 9.29e-09 | 555 | 198 | 20 | M2343 |
| Coexpression | ODONNELL_TFRC_TARGETS_DN | CENPF BRCA2 ANLN BUB1 KIF11 KRT35 KIF20A RIF1 SHCBP1 CDC6 HELLS | 9.31e-09 | 139 | 198 | 11 | M6451 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | CENPF BRCA2 BUB1 ETAA1 KIF11 KNL1 CEP192 CCDC77 LGR5 AKAP12 SPAG5 KIF20A DNAAF2 DDIAS RIF1 SHCBP1 IFFO2 KIF4B CDC6 HELLS | 3.11e-08 | 597 | 198 | 20 | MM1309 |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_UP | CENPF STK26 BRCA1 ANLN BUB1 PRR14L CASP8AP2 LCORL CEP192 RIF1 AKAP9 N4BP2 SHCBP1 CDC6 TP53BP1 ZNF239 HELLS | 3.83e-08 | 434 | 198 | 17 | M15150 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | CENPF BRCA2 BUB1 ETAA1 KIF11 KNL1 CEP192 CCDC77 LGR5 AKAP12 SPAG5 KIF20A DNAAF2 DDIAS RIF1 SHCBP1 IFFO2 CDC6 HELLS | 9.41e-08 | 578 | 198 | 19 | M2368 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | HIVEP2 CENPF DAPK1 RABGAP1 CEP350 PTPN12 BRCA1 PHIP MED13 GOLGA4 KIF11 PMS1 DNAJC13 C2CD2 AKAP9 NCOA1 ZNF292 | 1.06e-07 | 466 | 198 | 17 | M13522 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | TRIM24 TRIP11 DMXL1 CEP350 BRCA1 ANLN ETAA1 GOLGA4 KIF11 KNL1 IPO5 CASP8AP2 DNAJC13 APC CEP192 ARHGAP5 RIF1 RESF1 RAI14 HELLS | 1.43e-07 | 656 | 198 | 20 | M18979 |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_12H_UP | RBM44 CENPF BRCA1 BRCA2 BUB1 KIF11 KNL1 SPAG5 SHCBP1 CDC6 HELLS | 1.98e-07 | 187 | 198 | 11 | M2984 |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_UP | CENPF STK26 BRCA1 ANLN BUB1 PRR14L CASP8AP2 CEP192 RIF1 AKAP9 N4BP2 SHCBP1 CDC6 TP53BP1 ZNF239 HELLS | 3.40e-07 | 448 | 198 | 16 | MM1044 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_UP | 4.87e-07 | 163 | 198 | 10 | M8235 | |
| Coexpression | GSE13547_2H_VS_12_H_ANTI_IGM_STIM_ZFX_KO_BCELL_DN | 8.88e-07 | 174 | 198 | 10 | M2996 | |
| Coexpression | WHITFIELD_CELL_CYCLE_LITERATURE | 9.57e-07 | 44 | 198 | 6 | M2066 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C6_DEUTEROSOMAL_CELL | CENPF CADM1 BRCA2 ANLN BUB1 KNL1 KRT81 SPAG5 KIF20A CCDC171 HELLS | 1.04e-06 | 221 | 198 | 11 | M45789 |
| Coexpression | HEVNER_CORTEX_RADIAL_GLIA_PROGENITORS | PRKD3 BRCA2 ANLN GLI3 CCDC86 KIF11 KNL1 CEP192 SPAG5 SHCBP1 DUSP16 KIF4B PRKD1 CDC6 HELLS | 1.14e-06 | 432 | 198 | 15 | MM419 |
| Coexpression | ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER | 1.25e-06 | 140 | 198 | 9 | M15664 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_NK_CELL | CCP110 CENPF ZGRF1 TRIM24 BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 CASP8AP2 CEP192 SPAG5 KIF20A RIF1 SHCBP1 CDC6 PCNT HELLS | 1.49e-06 | 694 | 198 | 19 | M45767 |
| Coexpression | CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP | 1.67e-06 | 145 | 198 | 9 | M3045 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_PROMONOCYTE_LIKE_CELL | CENPF PTK2B BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A SHCBP1 HELLS | 2.33e-06 | 290 | 198 | 12 | M45736 |
| Coexpression | SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6 | CENPF BRCA2 AFP BUB1 KIF11 IPO5 DSP ARFGEF2 SPAG5 KIF20A GLMN RIF1 SHCBP1 CDC6 HELLS | 2.33e-06 | 458 | 198 | 15 | M8520 |
| Coexpression | RAO_BOUND_BY_SALL4_ISOFORM_B | CCP110 SH3BP4 BTN2A2 PTPN12 ANLN PHIP KNL1 IPO5 COPG2 CGGBP1 TRIM5 RIF1 SETD5 SHCBP1 SYPL2 RAI14 | 2.76e-06 | 526 | 198 | 16 | M2520 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL | CCP110 CENPF ZGRF1 BRCA1 BRCA2 ANLN BUB1 MED13 KIF11 KNL1 PMS1 IPO5 CASP8AP2 CEP192 SPAG5 KIF20A RIF1 N4BP2 SHCBP1 CDC6 PCNT HELLS | 2.78e-06 | 939 | 198 | 22 | M45768 |
| Coexpression | FAN_EMBRYONIC_CTX_MICROGLIA_1 | 2.90e-06 | 155 | 198 | 9 | M39041 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 2.99e-06 | 199 | 198 | 10 | M5893 | |
| Coexpression | GSE411_WT_VS_SOCS3_KO_MACROPHAGE_IL6_STIM_100MIN_UP | CENPF ACTR10 BRCA1 BUB1 DNAJC13 LCORL CEP192 DDIAS SHCBP1 ALPK2 | 3.12e-06 | 200 | 198 | 10 | M5992 |
| Coexpression | GSE15750_DAY6_VS_DAY10_EFF_CD8_TCELL_UP | 3.12e-06 | 200 | 198 | 10 | M3577 | |
| Coexpression | GSE12392_CD8A_POS_VS_NEG_SPLEEN_DC_DN | CENPF DAPK1 BRCA1 ANLN KIF11 RNF213 CEP192 ATP10A SPAG5 SHCBP1 | 3.12e-06 | 200 | 198 | 10 | M7143 |
| Coexpression | SASSON_RESPONSE_TO_GONADOTROPHINS_DN | 4.10e-06 | 86 | 198 | 7 | M17143 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | CCP110 CENPF ZGRF1 BRCA2 ANLN TMEM132A KIF11 KNL1 IPO5 SPAG5 KIF20A RIF1 SHCBP1 KIF4B CDC6 TP53BP1 ZNF239 HELLS | 4.54e-06 | 680 | 198 | 18 | MM456 |
| Coexpression | MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN | 5.56e-06 | 59 | 198 | 6 | M12661 | |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP | TET2 BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 DDIAS SHCBP1 CDC6 HELLS | 7.00e-06 | 323 | 198 | 12 | M2156 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_EARLY_STALK_CELL | CENPF ZGRF1 GALNT16 BRCA1 BRCA2 ANLN STARD9 BUB1 KDM2B KCNMB4 KIF11 KNL1 SPAG5 KIF20A SHCBP1 CDC6 | 7.12e-06 | 567 | 198 | 16 | M45692 |
| Coexpression | KONG_E2F3_TARGETS | 9.13e-06 | 97 | 198 | 7 | MM1105 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 9.80e-06 | 180 | 198 | 9 | M8239 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | CENPF PTPN12 BRCA2 GPR158 ANLN PHIP KIF11 KNL1 PMS1 DNAJC13 LCORL RBBP6 LARS1 APC ARFGEF2 ARHGAP5 RIF1 RESF1 | 1.01e-05 | 721 | 198 | 18 | M10237 |
| Coexpression | GSE14415_INDUCED_VS_NATURAL_TREG_DN | 1.02e-05 | 181 | 198 | 9 | M2969 | |
| Coexpression | RAO_BOUND_BY_SALL4_ISOFORM_B | CCP110 SH3BP4 BTN2A2 PTPN12 ANLN PHIP KNL1 IPO5 COPG2 CGGBP1 TRIM5 RIF1 SETD5 SHCBP1 SYPL2 RAI14 | 1.03e-05 | 584 | 198 | 16 | MM1080 |
| Coexpression | KONG_E2F3_TARGETS | 1.12e-05 | 100 | 198 | 7 | M1157 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_SCHWANN_PRECURSOR_CELL | 1.16e-05 | 232 | 198 | 10 | M45800 | |
| Coexpression | HOWARD_NK_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_3DY_UP | 1.28e-05 | 68 | 198 | 6 | M41108 | |
| Coexpression | BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_DN | 1.33e-05 | 187 | 198 | 9 | M34027 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_LARGE_PRE_B_CELL | CCP110 CENPF TMEM214 TRIM24 BRCA1 BRCA2 ANLN BUB1 CCDC86 KIF11 KNL1 PMS1 IPO5 CASP8AP2 LCORL COPG2 CEP192 CCDC77 SPAG5 KIF20A RIF1 N4BP2 SHCBP1 CDC6 PCNT HELLS | 1.35e-05 | 1363 | 198 | 26 | M45782 |
| Coexpression | GABRIELY_MIR21_TARGETS | RABGAP1 KLHL3 PHIP GOLGA4 KNL1 LCORL COBLL1 APC RAI14 ANO3 ZNF292 | 1.36e-05 | 289 | 198 | 11 | M2196 |
| Coexpression | ZHONG_PFC_C1_OPC | 1.44e-05 | 238 | 198 | 10 | M39096 | |
| Coexpression | BURTON_ADIPOGENESIS_3 | 1.44e-05 | 104 | 198 | 7 | MM1180 | |
| Coexpression | FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN | 1.51e-05 | 190 | 198 | 9 | M761 | |
| Coexpression | FISCHER_DREAM_TARGETS | CENPF ZGRF1 BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 CASP8AP2 LCORL RBBP6 CEP192 CCDC77 SPAG5 KIF20A DDIAS RIF1 SHCBP1 CDC6 PCNT HELLS | 1.54e-05 | 969 | 198 | 21 | M149 |
| Coexpression | MARKEY_RB1_ACUTE_LOF_UP | 1.55e-05 | 240 | 198 | 10 | MM976 | |
| Coexpression | GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_IFNAR_KO_DN | 1.64e-05 | 192 | 198 | 9 | M9983 | |
| Coexpression | VEGF_A_UP.V1_DN | 1.71e-05 | 193 | 198 | 9 | M2675 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CH_MKI67HIGH_CELLS | 1.74e-05 | 107 | 198 | 7 | M39165 | |
| Coexpression | GSE29614_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_DN | 1.78e-05 | 194 | 198 | 9 | M4912 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPROGBP | CENPF ZGRF1 BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 LGR5 SPAG5 HELLS | 1.92e-05 | 300 | 198 | 11 | M39059 |
| Coexpression | GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY10_UP | 2.10e-05 | 198 | 198 | 9 | M4639 | |
| Coexpression | WILCOX_RESPONSE_TO_PROGESTERONE_UP | 2.23e-05 | 153 | 198 | 8 | M18058 | |
| Coexpression | GSE23502_BM_VS_COLON_TUMOR_MYELOID_DERIVED_SUPPRESSOR_CELL_DN | 2.27e-05 | 200 | 198 | 9 | M8088 | |
| Coexpression | GSE18893_TCONV_VS_TREG_24H_CULTURE_DN | 2.27e-05 | 200 | 198 | 9 | M7289 | |
| Coexpression | GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_UP | 2.27e-05 | 200 | 198 | 9 | M7168 | |
| Coexpression | GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY3_DN | 2.27e-05 | 200 | 198 | 9 | M8485 | |
| Coexpression | GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_DN | 2.27e-05 | 200 | 198 | 9 | M9277 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | TNFRSF25 HIVEP2 ITGA1 ITGB2 GATAD2B CEP350 PRKD3 PTK2B KMT2A PHIP MED13 DOCK8 RBBP6 SYNE1 HECTD4 RNF213 CGGBP1 RIF1 RESF1 AKAP9 SETD5 TLN1 JCHAIN NCOA1 VPS13B ZNF292 NCKAP1L | 2.31e-05 | 1492 | 198 | 27 | M40023 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_CYCLING_DC_CELL | RABEP2 CCP110 TCTN3 CENPF ZGRF1 STK26 BRCA1 BRCA2 ANLN BUB1 CCDC86 KIF11 KNL1 PMS1 IPO5 CASP8AP2 COPG2 CEP192 SPAG5 KIF20A GLMN N4BP2 SHCBP1 CDC6 PCNT HELLS | 2.82e-05 | 1423 | 198 | 26 | M45722 |
| Coexpression | AFFAR_YY1_TARGETS_DN | CENPF BUB1 KIF11 PCDHB12 LGR5 SPAG5 KIF20A SHCBP1 CDC6 HELLS | 3.07e-05 | 260 | 198 | 10 | M1471 |
| Coexpression | MARSON_BOUND_BY_E2F4_UNSTIMULATED | CCP110 BRCA2 ANLN BUB1 ETAA1 KIF11 KNL1 CASP8AP2 ATP10A SPAG5 KIF20A SETD5 SHCBP1 CTNNA3 CDC6 PCNT HELLS | 3.26e-05 | 714 | 198 | 17 | M1744 |
| Coexpression | GRESHOCK_CANCER_COPY_NUMBER_UP | TRIM24 TRIP11 BRCA1 BRCA2 KMT2A KNL1 PMS1 APC RNF213 RUNX1T1 NCOA4 | 3.77e-05 | 323 | 198 | 11 | M9150 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_CYCLING_DEFINITIVE_ERYTHROBLAST | CCP110 CENPF BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A SHCBP1 CDC6 HELLS | 4.14e-05 | 450 | 198 | 13 | M45747 |
| Coexpression | SASSON_RESPONSE_TO_FORSKOLIN_DN | 4.59e-05 | 85 | 198 | 6 | M12924 | |
| Coexpression | KUMAMOTO_RESPONSE_TO_NUTLIN_3A_DN | 4.90e-05 | 10 | 198 | 3 | M6379 | |
| Coexpression | YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP | 5.00e-05 | 53 | 198 | 5 | M16542 | |
| Coexpression | GSE40274_CTRL_VS_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | 6.06e-05 | 176 | 198 | 8 | M9137 | |
| Coexpression | AFFAR_YY1_TARGETS_DN | CENPF BUB1 KIF11 PCDHB12 LGR5 SPAG5 KIF20A SHCBP1 CDC6 HELLS | 6.27e-05 | 283 | 198 | 10 | MM1157 |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | TCTN3 CENPF ZGRF1 ITGA1 TRIM24 BRCA1 BRCA2 ANLN BUB1 POP1 KIF11 KNL1 PMS1 IPO5 CASP8AP2 LARS1 RNF213 CEP192 CCDC77 SPAG5 KIF20A RIF1 RAI14 CDC6 HELLS | 6.39e-05 | 1407 | 198 | 25 | M14427 |
| Coexpression | TANG_SENESCENCE_TP53_TARGETS_DN | 6.53e-05 | 56 | 198 | 5 | M6171 | |
| Coexpression | WU_APOPTOSIS_BY_CDKN1A_NOT_VIA_TP53 | 6.70e-05 | 11 | 198 | 3 | M6312 | |
| Coexpression | CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP | 6.82e-05 | 179 | 198 | 8 | M3268 | |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_2H_UP | 7.97e-05 | 183 | 198 | 8 | M2993 | |
| Coexpression | NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER | 8.08e-05 | 94 | 198 | 6 | M18108 | |
| Coexpression | MARKEY_RB1_ACUTE_LOF_UP | 8.48e-05 | 237 | 198 | 9 | M15606 | |
| Coexpression | DESERT_STEM_CELL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP | 9.93e-05 | 242 | 198 | 9 | M34034 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 1.02e-04 | 300 | 198 | 10 | M8702 | |
| Coexpression | GSE45365_WT_VS_IFNAR_KO_BCELL_DN | 1.11e-04 | 192 | 198 | 8 | M9987 | |
| Coexpression | BURTON_ADIPOGENESIS_3 | 1.20e-04 | 101 | 198 | 6 | M1577 | |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP | CENPF TMEM132B PRKD3 KCNQ5 BRCA1 BRCA2 ANLN LRFN5 BUB1 POP1 CCDC86 KIF11 KNL1 CASP8AP2 LARS1 AKAP12 DDIAS RIF1 N4BP2 PRKD1 CDC6 HELLS NCKAP1L | 1.22e-04 | 1290 | 198 | 23 | M80 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP | CENPF TRIP11 PTPN12 BRCA1 ANLN KNL1 PMS1 APC CCDC77 RIF1 RESF1 SHCBP1 RAI14 CDC6 HELLS | 1.22e-04 | 644 | 198 | 15 | M10501 |
| Coexpression | GREENBAUM_E2A_TARGETS_UP | 1.23e-04 | 34 | 198 | 4 | MM1160 | |
| Coexpression | GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4_KO_BCELL_DN | 1.24e-04 | 195 | 198 | 8 | M9808 | |
| Coexpression | GSE14350_TREG_VS_TEFF_UP | 1.42e-04 | 199 | 198 | 8 | M3417 | |
| Coexpression | GSE10239_KLRG1INT_VS_KLRG1HIGH_EFF_CD8_TCELL_DN | 1.42e-04 | 199 | 198 | 8 | M3070 | |
| Coexpression | GSE12839_CTRL_VS_IL12_TREATED_PBMC_UP | 1.43e-04 | 149 | 198 | 7 | M442 | |
| Coexpression | GSE36078_UNTREATED_VS_AD5_INF_IL1R_KO_MOUSE_LUNG_DC_UP | 1.47e-04 | 200 | 198 | 8 | M9301 | |
| Coexpression | GSE40685_NAIVE_CD4_TCELL_VS_TREG_DN | 1.47e-04 | 200 | 198 | 8 | M9303 | |
| Coexpression | GSE15215_CD2_POS_VS_NEG_PDC_DN | 1.47e-04 | 200 | 198 | 8 | M3521 | |
| Coexpression | GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_UP | 1.47e-04 | 200 | 198 | 8 | M3580 | |
| Coexpression | GSE27786_LIN_NEG_VS_ERYTHROBLAST_DN | 1.47e-04 | 200 | 198 | 8 | M4793 | |
| Coexpression | GSE30962_PRIMARY_VS_SECONDARY_ACUTE_LCMV_INF_CD8_TCELL_UP | 1.47e-04 | 200 | 198 | 8 | M5041 | |
| Coexpression | GSE24210_CTRL_VS_IL35_TREATED_TCONV_CD4_TCELL_UP | 1.47e-04 | 200 | 198 | 8 | M7841 | |
| Coexpression | GSE40666_WT_VS_STAT1_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN | 1.47e-04 | 200 | 198 | 8 | M9215 | |
| Coexpression | GSE40274_FOXP3_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 1.47e-04 | 200 | 198 | 8 | M9188 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | CCP110 RBM44 AFTPH CENPF TRIML2 ZGRF1 KIZ DMXL1 BRCA1 BRCA2 ANLN BUB1 ATF7IP2 MAP3K15 PMS1 CASP8AP2 DNAJC13 DSP ARFGEF2 COPG2 CEP192 TEX15 RUNX1T1 RNF17 ATP10A DDIAS RIF1 USP40 CCDC171 HELLS | 1.30e-10 | 820 | 197 | 30 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_500 | RBM44 CENPF TRIML2 BRCA1 BRCA2 ANLN BUB1 ATF7IP2 ETAA1 MAP3K15 PMS1 DNAJC13 CEP192 TEX15 RUNX1T1 RNF17 ATP10A DDIAS RIF1 HELLS | 6.21e-10 | 387 | 197 | 20 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_500 |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_1000 | CCP110 RBM44 CENPF TRIML2 ZGRF1 BRCA1 BRCA2 ANLN BUB1 POP1 ATF7IP2 ETAA1 MAP3K15 KIF11 PMS1 DNAJC13 LARS1 CEP192 TEX15 RUNX1T1 RNF17 ATP10A TRIM5 KIF20A DDIAS ZNF750 RIF1 HELLS | 1.35e-09 | 795 | 197 | 28 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_500 | RBM44 CENPF TRIML2 BRCA1 BRCA2 ANLN BUB1 ATF7IP2 MAP3K15 PMS1 DNAJC13 DSP CEP192 TEX15 RUNX1T1 RNF17 ATP10A DDIAS RIF1 HELLS | 1.42e-09 | 406 | 197 | 20 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_500 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_500 | CCP110 RBM44 CENPF ZGRF1 BRCA1 ANLN BUB1 ATF7IP2 ARFGEF2 RNF17 DDIAS RIF1 HELLS | 1.80e-09 | 152 | 197 | 13 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k2_500 |
| CoexpressionAtlas | dev gonad_e11.5_M_PrimGermCell_Oct_top-relative-expression-ranked_500 | RBM44 CENPF TRIML2 BRCA1 BRCA2 ANLN BUB1 ATF7IP2 ETAA1 MAP3K15 PMS1 DSP TEX15 RUNX1T1 RNF17 ATP10A DDIAS RIF1 HELLS | 2.47e-09 | 376 | 197 | 19 | gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_500 |
| CoexpressionAtlas | dev gonad_e11.5_M_PrimGermCell_Oct_top-relative-expression-ranked_1000 | RBM44 CENPF TRIML2 BRCA1 BRCA2 ANLN BUB1 POP1 ATF7IP2 ETAA1 MAP3K15 KIF11 PMS1 DNAJC13 DSP LARS1 CEP192 TEX15 RUNX1T1 RNF17 ATP10A TRIM5 DDIAS ZNF750 RIF1 CDC6 HELLS | 4.07e-09 | 781 | 197 | 27 | gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_PrimGermCell_Oct_top-relative-expression-ranked_1000 | RBM44 CENPF TRIML2 ZGRF1 BRCA1 BRCA2 ANLN BUB1 ATF7IP2 ETAA1 MAP3K15 KIF11 PMS1 DNAJC13 DSP LARS1 ARFGEF2 CEP192 TEX15 RUNX1T1 RNF17 ATP10A TRIM5 KIF20A DDIAS RIF1 HELLS | 6.60e-09 | 799 | 197 | 27 | gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000 | RBM44 CENPF TRIML2 KIZ BRCA1 BRCA2 ANLN BUB1 POP1 ATF7IP2 MAP3K15 PMS1 DNAJC13 LARS1 RNF213 COPG2 CEP192 TEX15 RUNX1T1 RNF17 ATP10A TRIM5 DDIAS ZNF750 RIF1 CCDC171 HELLS | 8.80e-09 | 810 | 197 | 27 | gudmap_dev gonad_e13.5_M_GermCell_Oct_1000 |
| CoexpressionAtlas | B cells, preB.FrC.BM, CD19+ IgM- CD45R+ CD43+ HSA+, Bone marrow, avg-3 | 9.05e-09 | 88 | 197 | 10 | GSM399452_100 | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000 | CCP110 RBM44 CENPF TRIML2 ZGRF1 BRCA1 BRCA2 ANLN BUB1 ATF7IP2 ETAA1 MAP3K15 KIF11 PMS1 DNAJC13 DSP ARFGEF2 RNF213 CEP192 TEX15 RUNX1T1 RNF17 ATP10A TRIM5 DDIAS RIF1 HELLS | 1.20e-08 | 822 | 197 | 27 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_500 | CCP110 RBM44 CENPF TRIML2 ZGRF1 BRCA1 BRCA2 ANLN BUB1 ATF7IP2 MAP3K15 CASP8AP2 ARFGEF2 TEX15 RNF17 DDIAS RIF1 HELLS | 2.20e-08 | 385 | 197 | 18 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_500 |
| CoexpressionAtlas | dev gonad_e11.5_F_PrimGermCell_Oct_top-relative-expression-ranked_500 | RBM44 CENPF TRIML2 BRCA1 BRCA2 ANLN BUB1 ATF7IP2 ETAA1 PMS1 DSP TEX15 RUNX1T1 RNF17 ATP10A DDIAS RIF1 HELLS | 2.29e-08 | 386 | 197 | 18 | gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | CENPF KIZ BRCA1 BRCA2 GLI3 PHIP GOLGA4 KNL1 CASP8AP2 RBBP6 CEP162 ARFGEF2 SPAG5 RIF1 AKAP9 ZNF292 | 3.70e-08 | 311 | 197 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | CCP110 RBM44 CENPF ZGRF1 KIZ BRCA1 BRCA2 ANLN BUB1 ATF7IP2 CASP8AP2 DNAJC13 ARFGEF2 COPG2 CEP192 RNF17 HELLS | 4.96e-08 | 361 | 197 | 17 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k2_1000 |
| CoexpressionAtlas | B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R+ CD, Fetal Liver, avg-2 | 1.42e-07 | 89 | 197 | 9 | GSM538355_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | ZNF536 AFTPH CENPF KIZ USP44 CADM1 BRCA1 BRCA2 GLI3 PHIP GOLGA4 KNL1 CASP8AP2 RBBP6 CEP162 ARFGEF2 DLL1 SPAG5 GLMN RIF1 SCUBE2 AKAP9 CDC6 CCDC171 CFAP69 CEACAM20 ZNF292 PCNT | 1.43e-07 | 989 | 197 | 28 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | alpha beta T cells, T.DPbl.Th, 4+ 8+ TCR-/lo FSChi, Thymus, avg-3 | 1.57e-07 | 90 | 197 | 9 | GSM399397_100 | |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_500 | RBM44 CENPF TRIML2 BRCA2 BUB1 ATF7IP2 MAP3K15 PMS1 CEP192 TEX15 RNF17 ATP10A TRIM5 DDIAS RIF1 CCDC171 HELLS | 1.87e-07 | 396 | 197 | 17 | gudmap_dev gonad_e13.5_M_GermCell_Oct_500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | CCP110 CENPF ZGRF1 TRIM24 CEP350 PTPN12 BRCA1 BRCA2 ANLN GLI3 BUB1 ETAA1 CCDC86 PHIP KIF11 KNL1 PMS1 CASP8AP2 RBBP6 APC ARFGEF2 CEP192 RWDD3 CCDC77 SPAG5 ARHGAP5 RIF1 AKAP9 SETD5 TP53BP1 ZNF292 HELLS | 1.87e-07 | 1257 | 197 | 32 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | alpha beta T cells, T.DPbl.Th, 4+ 8+ TCR-/lo FSChi, Thymus, avg-3 | CCP110 CENPF ZGRF1 BRCA1 BRCA2 ANLN BUB1 ENDOU KIF11 KNL1 ATP10A AKAP12 SPAG5 KIF20A DDIAS SHCBP1 HELLS | 2.00e-07 | 398 | 197 | 17 | GSM399397_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | ZNF536 AFTPH CENPF GALNT16 CEP350 BRCA1 STARD9 GLI3 PHIP CASP8AP2 RBBP6 PPP1R9A HECTD4 SPAG5 DNAAF2 RIF1 AKAP9 DUSP16 USP40 NCOA1 CFAP69 PCNT | 2.01e-07 | 654 | 197 | 22 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | CENPF CEP350 ANLN BUB1 KIF11 CASP8AP2 TEX15 RUNX1T1 DDIAS USP40 | 2.27e-07 | 123 | 197 | 10 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k3_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | CENPF BRCA1 BRCA2 GLI3 PHIP GOLGA4 KNL1 CASP8AP2 ARFGEF2 SPAG5 RIF1 AKAP9 | 2.50e-07 | 192 | 197 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d5.VSVOva, CD8+ CD45.1+, Spleen, avg-3 | CENPF ZGRF1 ITGA1 BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 COBLL1 ATP10A SPAG5 KIF20A DDIAS SHCBP1 CDC6 HELLS | 3.04e-07 | 410 | 197 | 17 | GSM538387_500 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.07e-07 | 71 | 197 | 8 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k2_1000 | |
| CoexpressionAtlas | alpha beta T cells, T.ISP.Th, 4- 8+ TCR-/lo 24hi, Thymus, avg-3 | CCP110 CENPF ZGRF1 BRCA1 BRCA2 ANLN BUB1 ENDOU KIF11 KNL1 SPAG5 KIF20A DDIAS RIF1 SHCBP1 CDC6 HELLS | 3.86e-07 | 417 | 197 | 17 | GSM399403_500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | CCP110 CENPF STK26 TRIM24 BRCA1 BRCA2 GLI3 BUB1 POP1 RNF10 ETAA1 BAMBI KCNMB4 CCDC86 PHIP KNL1 CASP8AP2 APC ARFGEF2 CEP192 RUNX1T1 SPAG5 DDIAS ARHGAP5 GLMN RIF1 RESF1 AKAP9 SETD5 SHCBP1 ZNF292 | 4.51e-07 | 1241 | 197 | 31 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | dev gonad_e11.5_F_PrimGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.45e-07 | 104 | 197 | 9 | gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_k2_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | CCP110 ZNF536 CENPF ZGRF1 TRIM24 CEP350 PTPN12 KCNQ5 BRCA1 BRCA2 ANLN GLI3 BUB1 ETAA1 CCDC86 PHIP KIF11 KNL1 PMS1 CASP8AP2 RBBP6 APC ARFGEF2 CEP192 RWDD3 CCDC77 SPAG5 ARHGAP5 RIF1 AKAP9 SETD5 TP53BP1 ZNF292 HELLS | 5.76e-07 | 1459 | 197 | 34 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | CENPF KSR1 PTPN12 BRCA1 BRCA2 ANLN GLI3 BUB1 ETAA1 PHIP KIF11 CASP8AP2 CEP192 RWDD3 SPAG5 DNAAF2 RIF1 N4BP2 PCNT | 5.87e-07 | 532 | 197 | 19 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | CCP110 ZNF536 CENPF STK26 TRIM24 BRCA1 BRCA2 GLI3 BUB1 POP1 RNF10 ETAA1 BAMBI KCNMB4 CCDC86 PHIP KNL1 CASP8AP2 PSCA APC ARFGEF2 CEP192 RUNX1T1 SPAG5 DDIAS ARHGAP5 GLMN RIF1 RESF1 AKAP9 SETD5 SHCBP1 CD40 ZNF292 | 6.63e-07 | 1468 | 197 | 34 | facebase_RNAseq_e10.5_MandArch_2500 |
| CoexpressionAtlas | dev gonad_e11.5_M_PrimGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | CENPF BRCA1 ANLN BUB1 ATF7IP2 KIF11 PMS1 DNAJC13 CEP192 RUNX1T1 RIF1 CDC6 HELLS | 9.24e-07 | 258 | 197 | 13 | gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_k2_1000 |
| CoexpressionAtlas | B cells, preB.FrD.FL, AA4.1+ IgM- CD19+ CD43- CD24+, Fetal Liver, avg-3 | CENPF ZGRF1 KCNQ5 BRCA1 ANLN BUB1 ENDOU KIF11 KNL1 LGR5 AKAP12 SPAG5 KIF20A N4BP2 SHCBP1 HELLS | 9.35e-07 | 395 | 197 | 16 | GSM538340_500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | RBM44 STK26 TRIM24 DMXL1 PTPN12 BRCA1 BRCA2 AFP BUB1 ATF7IP2 DNAJC13 LCORL RNF213 TEX15 RNF17 LGR5 TRIM5 ARHGAP5 RIF1 RESF1 CCNB3 USP40 HELLS | 9.51e-07 | 776 | 197 | 23 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | alpha beta T cells, NKT.44-NK1.1-.Th, aGC CD1d tet CD3e, Thymus, avg-2 | ZNF536 CENPF KCNQ5 BRCA1 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A DDIAS RIF1 IKBKE SHCBP1 CDC6 HELLS | 1.03e-06 | 398 | 197 | 16 | GSM538338_500 |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | CCP110 RBM44 CENPF ZGRF1 BRCA1 ANLN BUB1 ATF7IP2 KIF11 DNAJC13 CEP192 RNF17 HELLS | 1.30e-06 | 266 | 197 | 13 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_k2_1000 |
| CoexpressionAtlas | B cells, preB.FrC.BM, CD19+ IgM- CD45R+ CD43+ HSA+, Bone marrow, avg-3 | CENPF ZGRF1 BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 LGR5 AKAP12 SPAG5 KIF20A DDIAS SHCBP1 CDC6 HELLS | 1.47e-06 | 409 | 197 | 16 | GSM399452_500 |
| CoexpressionAtlas | B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Fetal Liver, avg-1 | 1.62e-06 | 88 | 197 | 8 | GSM538357_100 | |
| CoexpressionAtlas | alpha beta T cells, T.ISP.Th, 4- 8+ TCR-/lo 24hi, Thymus, avg-3 | 1.93e-06 | 90 | 197 | 8 | GSM399403_100 | |
| CoexpressionAtlas | B cells, B.FrE.FL, AA4.1+ IgM+ CD19+ CD43- CD24+, Fetal Liver, avg-3 | CENPF DMXL1 KCNQ5 ANLN BUB1 ENDOU MED13 KIF11 KNL1 COBLL1 AKAP12 SPAG5 N4BP2 CD40 HELLS | 2.19e-06 | 372 | 197 | 15 | GSM538204_500 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_1000 | RBM44 CENPF KIZ BRCA1 ANLN BUB1 ATF7IP2 DNAJC13 LARS1 COPG2 CEP192 RNF17 RIF1 HELLS | 2.98e-06 | 333 | 197 | 14 | gudmap_dev gonad_e13.5_M_GermCell_Oct_k1_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_PrimGermCell_Oct_k-means-cluster#4_top-relative-expression-ranked_500 | 3.11e-06 | 44 | 197 | 6 | gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_k4_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.67e-06 | 98 | 197 | 8 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k2_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#1_top-relative-expression-ranked_1000 | STK26 RABGAP1 GATAD2B CEP350 GLI3 MED13 RBBP6 PCDHB12 APC ARFGEF2 TNKS | 4.28e-06 | 209 | 197 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | ZNF536 CENPF USP44 CADM1 BRCA1 BRCA2 GLI3 PHIP GOLGA4 KNL1 CASP8AP2 ARFGEF2 DLL1 SPAG5 RIF1 SCUBE2 AKAP9 | 4.32e-06 | 498 | 197 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#4_top-relative-expression-ranked_500 | 4.60e-06 | 101 | 197 | 8 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k4_500 | |
| CoexpressionAtlas | alpha beta T cells, preT.DN3-4.Th, Lin-/lo CD25int CD44- CD28+, Thymus, avg-3 | CENPF ZGRF1 BRCA1 BRCA2 ANLN BUB1 ENDOU KIF11 KNL1 SPAG5 KIF20A DDIAS SHCBP1 CDC6 HELLS | 4.83e-06 | 397 | 197 | 15 | GSM791143_500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_1000 | 5.80e-06 | 138 | 197 | 9 | gudmap_developingGonad_e12.5_epididymis_k5_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_k-means-cluster#1_top-relative-expression-ranked_500 | 6.15e-06 | 105 | 197 | 8 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_k1_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_PrimGermCell_Oct_k-means-cluster#3_top-relative-expression-ranked_1000 | CENPF TRIML2 BRCA1 ANLN BUB1 ETAA1 KIF11 PMS1 DNAJC13 LARS1 CEP192 ATP10A TRIM5 KIF20A DDIAS RIF1 | 7.17e-06 | 463 | 197 | 16 | gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_k3_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | CENPF KIZ TRIM24 DMXL1 BRCA2 ANLN GLI3 BUB1 ETAA1 PHIP APC CEP192 KIF20A RIF1 AKAP9 ZNF292 | 8.42e-06 | 469 | 197 | 16 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#3_top-relative-expression-ranked_200 | 9.12e-06 | 31 | 197 | 5 | gudmap_developingGonad_e14.5_ ovary_200_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000 | RABGAP1 GATAD2B CEP350 PHIP MED13 APC ARFGEF2 LGR5 SPAG5 AKAP9 SETD5 TNKS VPS13B ZNF292 | 9.63e-06 | 369 | 197 | 14 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000 |
| CoexpressionAtlas | B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Fetal Liver, avg-1 | CENPF ZGRF1 BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A DDIAS JCHAIN SHCBP1 CDC6 HELLS | 1.00e-05 | 422 | 197 | 15 | GSM538357_500 |
| CoexpressionAtlas | B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R+ CD, Fetal Liver, avg-2 | CENPF ZGRF1 BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 COBLL1 SPAG5 KIF20A DDIAS SHCBP1 CDC6 HELLS | 1.00e-05 | 422 | 197 | 15 | GSM538355_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | TCTN3 ZNF536 AFTPH CENPF KIZ BRCA1 BRCA2 GLI3 PRR14L PHIP GOLGA4 KNL1 CASP8AP2 RBBP6 CEP162 TRIM39 SPAG5 RIF1 AKAP9 CCDC171 CFAP69 ZNF292 | 1.01e-05 | 831 | 197 | 22 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | MYH3 STK26 RABGAP1 GATAD2B CEP350 AFP GLI3 BAMBI MED13 TBX3 LCORL DSP RBBP6 KRT35 PCDHB12 APC ARFGEF2 RUNX1T1 RIF1 RAI14 TNKS | 1.02e-05 | 769 | 197 | 21 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_200 | 1.02e-05 | 148 | 197 | 9 | gudmap_developingGonad_e14.5_ ovary_200 | |
| CoexpressionAtlas | B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R- CD, Fetal Liver, avg-2 | 1.22e-05 | 83 | 197 | 7 | GSM538348_100 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | TET2 CCP110 ZNF536 CENPF TRIM24 IL1RL2 PRKD3 KSR1 PTPN12 BRCA2 GLI3 BUB1 ETAA1 BAMBI KNL1 CASP8AP2 APC CEP192 CCDC77 LGR5 DDIAS ARHGAP5 GLMN RIF1 RESF1 AKAP9 SETD5 ZNF292 | 1.40e-05 | 1252 | 197 | 28 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | alpha beta T cells, preT.DN3-4.Th, Lin-/lo CD25int CD44- CD28+, Thymus, avg-3 | 1.42e-05 | 85 | 197 | 7 | GSM791143_100 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_500 | RBM44 DMXL1 AFP ATF7IP2 DNAJC13 LCORL RNF213 TEX15 RNF17 LGR5 RIF1 RESF1 CCNB3 HELLS | 1.64e-05 | 387 | 197 | 14 | gudmap_developingGonad_e16.5_ovary_500 |
| CoexpressionAtlas | dev gonad_e11.5_F_PrimGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_500 | 2.33e-05 | 164 | 197 | 9 | gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_k2_500 | |
| CoexpressionAtlas | kidney_e10.5_UretericTip_HoxB7_k-means-cluster#4_top-relative-expression-ranked_1000 | CENPF CADM1 ANLN BUB1 ETAA1 KIF11 KNL1 CEP192 SPAG5 KIF20A RIF1 SHCBP1 HELLS | 2.37e-05 | 348 | 197 | 13 | gudmap_kidney_e10.5_UretericTip_HoxB7_k4_1000 |
| CoexpressionAtlas | B cells, proB.FrBC.BM, CD19+ IgM- CD43+ AA4.1+ CD45R+, Bone marrow, avg-2 | CENPF KCNQ5 BRCA1 ANLN BUB1 KIF11 KNL1 LGR5 AKAP12 SPAG5 KIF20A SHCBP1 CDC6 HELLS | 2.43e-05 | 401 | 197 | 14 | GSM399450_500 |
| CoexpressionAtlas | Stem Cells, SC.MEP.BM, Lineage- Kit+ Sca1- CD34- FcgR-/low, Bone marrow, avg-2 | ZGRF1 BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 PKHD1L1 SPAG5 KIF20A DDIAS SHCBP1 CDC6 HELLS | 2.43e-05 | 401 | 197 | 14 | GSM791108_500 |
| CoexpressionAtlas | Stem Cells, SC.MDP.BM, Sca1- Flt3+ MCSFR+ cKithi, Bone marrow, avg-3 | CENPF ZGRF1 BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A DDIAS SHCBP1 CDC6 HELLS | 2.50e-05 | 402 | 197 | 14 | GSM791105_500 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_FloorPlate_2500_K3 | CCP110 CENPF KIZ CADM1 BRCA1 BRCA2 GLI3 BUB1 ETAA1 ALDOA CCDC86 PHIP KIF11 KNL1 IPO5 CASP8AP2 COBLL1 MAP3K14 CEP192 AKAP12 DNAAF2 ARHGAP5 LINS1 RIF1 SCUBE2 AKAP9 SETD5 ZNF239 HELLS | 2.71e-05 | 1371 | 197 | 29 | facebase_RNAseq_e8.5_FloorPlate_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#2_top-relative-expression-ranked_200 | 3.10e-05 | 65 | 197 | 6 | gudmap_developingGonad_e12.5_ovary_k2_200 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#4_top-relative-expression-ranked_200 | 3.10e-05 | 20 | 197 | 4 | gudmap_developingGonad_e16.5_ovary_200_k4 | |
| CoexpressionAtlas | B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate CD45R- AA4.1+ CD, Fetal Liver, avg-1 | CENPF ZGRF1 BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A DDIAS SHCBP1 CDC6 HELLS | 3.82e-05 | 418 | 197 | 14 | GSM538350_500 |
| CoexpressionAtlas | B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R- CD, Fetal Liver, avg-2 | CENPF ZGRF1 BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A DDIAS SHCBP1 CDC6 HELLS | 3.92e-05 | 419 | 197 | 14 | GSM538348_500 |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_1000 | CCP110 CENPF BRCA1 GLI3 BUB1 KDM2B KIF11 KNL1 RBBP6 CEP192 DDIAS SHCBP1 | 4.18e-05 | 316 | 197 | 12 | gudmap_kidney_P3_CapMes_Crym_k4_1000 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2-24ahi.Th, TCRd+ Vg2- CD24+, Thymus, avg-2 | CENPF BRCA1 ANLN BUB1 ENDOU KIF11 KNL1 SPAG5 KIF20A IKBKE N4BP2 SHCBP1 CDC6 HELLS | 4.24e-05 | 422 | 197 | 14 | GSM476658_500 |
| CoexpressionAtlas | Fetal Liver, SC.LTSL.FL, IgM- CD24- CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Fetal Liver, avg-3 | CENPF ZGRF1 BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 PPP1R9A SPAG5 KIF20A SHCBP1 RAI14 HELLS | 4.35e-05 | 423 | 197 | 14 | GSM791126_500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_100 | 4.73e-05 | 70 | 197 | 6 | gudmap_developingGonad_e14.5_ ovary_100 | |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_200 | 4.75e-05 | 139 | 197 | 8 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_200 | |
| CoexpressionAtlas | B cells, proB.FrBC.BM, CD19+ IgM- CD45R+ CD43+ HSA+, Bone marrow, avg-1 | CENPF BRCA1 ANLN BUB1 KIF11 KNL1 LGR5 AKAP12 SPAG5 KIF20A SHCBP1 CDC6 HELLS | 5.26e-05 | 376 | 197 | 13 | GSM538418_500 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | RBM44 AFTPH TRIM24 HSF5 DMXL1 AFP ATF7IP2 DNAJC13 LCORL RNF213 TEX15 NCOA4 RNF17 LGR5 RIF1 RESF1 CCNB3 USP40 PRKD1 HELLS | 5.33e-05 | 795 | 197 | 20 | gudmap_developingGonad_e16.5_ovary_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_PrimGermCell_Oct_k-means-cluster#3_top-relative-expression-ranked_500 | 5.53e-05 | 142 | 197 | 8 | gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_k3_500 | |
| CoexpressionAtlas | B cells, B.GC.Sp, CD19+ IgM+ IgD- GL7+ PNA+, Spleen, avg-3 | CENPF BRCA1 ANLN BUB1 ENDOU KIF11 KNL1 SPAG5 KIF20A JCHAIN SHCBP1 CDC6 HELLS | 5.86e-05 | 380 | 197 | 13 | GSM538207_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | ZNF536 AFTPH CENPF GALNT16 CEP350 BRCA1 PHIP CASP8AP2 RBBP6 AKAP9 DUSP16 CCDC171 | 5.98e-05 | 328 | 197 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K2 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#4_top-relative-expression-ranked_1000 | 6.34e-05 | 107 | 197 | 7 | gudmap_developingGonad_e16.5_ovary_1000_k4 | |
| CoexpressionAtlas | B cells, preB.FrD.BM, CD19+ IgM- CD45R+ CD43-, Bone marrow, avg-3 | CENPF KCNQ5 ANLN BUB1 ENDOU KIF11 KNL1 LGR5 AKAP12 SPAG5 KIF20A SHCBP1 HELLS | 6.34e-05 | 383 | 197 | 13 | GSM399448_500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | RBM44 STK26 TRIM24 DMXL1 PTK2B PTPN12 BRCA1 AFP KNL1 DNAJC13 LCORL RNF213 RUNX1T1 RNF17 LGR5 TRIM5 RIF1 RESF1 USP40 HELLS | 6.45e-05 | 806 | 197 | 20 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | ZNF536 CENPF BRCA1 BRCA2 GLI3 PHIP CASP8AP2 SPAG5 RIF1 AKAP9 | 6.48e-05 | 232 | 197 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | RABGAP1 GATAD2B CEP350 GLI3 PHIP MED13 PPP1R9A APC TRIM5 AKAP9 SETD5 TNKS VPS13B | 6.69e-05 | 385 | 197 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | CCP110 ZNF536 BRPF3 CENPF TRIM24 CADM1 BRCA1 BRCA2 BUB1 ETAA1 KDM2B PHIP KIF11 KNL1 PMS1 CASP8AP2 CEP162 APC COPG2 CCDC77 DLL1 ATP10A SPAG5 AKAP9 SETD5 TP53BP1 ZNF239 HELLS | 6.91e-05 | 1370 | 197 | 28 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_200 | 7.06e-05 | 147 | 197 | 8 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_200 | |
| CoexpressionAtlas | B cells, proB.FrA.BM, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Bone marrow, avg-2 | CENPF ZGRF1 BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A SHCBP1 CDC6 HELLS | 7.23e-05 | 388 | 197 | 13 | GSM538352_500 |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#2_top-relative-expression-ranked_500 | 7.41e-05 | 148 | 197 | 8 | gudmap_kidney_P3_CapMes_Crym_k2_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | RABGAP1 GATAD2B CEP350 KCNQ5 AFP GLI3 BAMBI PHIP MED13 TBX3 DSP PPP1R9A PCDHB12 APC RUNX1T1 TRIM5 AKAP9 SETD5 TNKS VPS13B | 7.89e-05 | 818 | 197 | 20 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | B cells, B.Pl.AA4+220-.BM, CD138+ AA4.1+ CD43- CD45R-, Bone marrow, avg-3 | ITGA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A JCHAIN SHCBP1 CDC6 HELLS | 8.19e-05 | 339 | 197 | 12 | GSM777027_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_500 | 8.62e-05 | 194 | 197 | 9 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#3_top-relative-expression-ranked_500 | 9.47e-05 | 114 | 197 | 7 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k3_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#4_top-relative-expression-ranked_1000 | RBM44 TRIML2 MAP3K15 PMS1 DNAJC13 CEP192 RNF17 TRIM5 DDIAS RIF1 | 9.52e-05 | 243 | 197 | 10 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k4_1000 |
| CoexpressionAtlas | B cells, proB.CLP.BM, CD19- IgM- CD43+ CD24intermediate CD45R- AA4.1+ CD, Bone marrow, avg-2 | CENPF ZGRF1 BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 COBLL1 SPAG5 KIF20A CDC6 HELLS | 9.57e-05 | 399 | 197 | 13 | GSM538345_500 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000 | CCP110 CENPF STK26 DAPK1 TRIM24 CEP350 PRKD3 BRCA2 GLI3 BUB1 TBX3 LCORL RNF213 TEX15 RUNX1T1 DDIAS GLMN RESF1 SHCBP1 PRKD1 | 9.77e-05 | 831 | 197 | 20 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | B cells, proB.FrBC.FL, CD19+ IgM- CD43+ CD24+ AA4.1+ CD45R+, Fetal Liver, avg-3 | CENPF ZGRF1 BRCA1 ANLN BUB1 KIF11 KNL1 AKAP12 SPAG5 KIF20A SHCBP1 CDC6 HELLS | 9.82e-05 | 400 | 197 | 13 | GSM538358_500 |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | KIZ TRIM24 AFP PHIP MED13 GOLGA4 TBX3 DSP PPP1R9A WDR59 AKAP9 TNKS PRKD1 ZNF292 | 2.43e-13 | 192 | 200 | 14 | 916fbec1c7ab7969bda711886ac88e877e30c280 |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | KIZ TRIM24 AFP PHIP MED13 GOLGA4 TBX3 DSP PPP1R9A WDR59 AKAP9 SETD5 TNKS ZNF292 | 2.61e-13 | 193 | 200 | 14 | e6a688bc834f845ff64dae1be64f073eec5091a1 |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | CENPF ZGRF1 BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A DDIAS SHCBP1 CDC6 HELLS | 3.97e-13 | 199 | 200 | 14 | be2276c9a1994579ba1d2998b49bf549c1324d44 |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-FOXM1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | CENPF ZGRF1 BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A DDIAS SHCBP1 CDC6 HELLS | 4.25e-13 | 200 | 200 | 14 | 4cfe08878a6981bf7b3567f9e82192d8f060ddde |
| ToppCell | Control_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type | CENPF ZGRF1 BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A DDIAS SHCBP1 CDC6 HELLS | 4.25e-13 | 200 | 200 | 14 | 9bbc7b5561151f6ff65f40b3226271def732e5d9 |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | KRT26 CENPF ZGRF1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A DDIAS SHCBP1 HELLS | 8.93e-13 | 169 | 200 | 13 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | CENPF ZGRF1 BRCA1 BRCA2 ANLN LRFN5 GLI3 BUB1 KIF11 KNL1 KIF20A ANO3 HELLS | 3.25e-12 | 187 | 200 | 13 | e41e39fd3791acf8ae5376cc5061e196d96868ae |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | CENPF ZGRF1 BRCA1 BRCA2 ANLN LRFN5 GLI3 BUB1 KIF11 KNL1 KIF20A ANO3 HELLS | 3.25e-12 | 187 | 200 | 13 | cefa211ef224e803ea9467882e2ca74d0b1492f1 |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | CENPF ZGRF1 BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 CCDC77 KIF20A SHCBP1 CDC6 HELLS | 3.25e-12 | 187 | 200 | 13 | 057569c9437219ecc396aa6e673b1178a2273837 |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | CENPF ZGRF1 BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A SHCBP1 CDC6 HELLS | 3.73e-12 | 189 | 200 | 13 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4/8-lo-Cycling_T|GI_small-bowel / Manually curated celltypes from each tissue | CENPF ZGRF1 BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A SHCBP1 CDC6 HELLS | 4.26e-12 | 191 | 200 | 13 | e642fa7395c05fb53324c9d46bbc52f89fc9673f |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|367C / Donor, Lineage, Cell class and subclass (all cells) | CENPF BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A SHCBP1 KIF4B CDC6 HELLS | 5.19e-12 | 194 | 200 | 13 | a12b64945e10f00aa983678a02586c59badc1570 |
| ToppCell | moderate-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | CCP110 CENPF CEP350 CADM1 BRCA1 BRCA2 ANLN BUB1 PHIP KNL1 CCDC171 PCNT HELLS | 5.19e-12 | 194 | 200 | 13 | dff3fb10372053951d41e0ccd41aac3ece6009bd |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | CENPF ZGRF1 BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A SHCBP1 CDC6 HELLS | 5.91e-12 | 196 | 200 | 13 | 1d2e0b328eb822db7521b5f5724d4bd17c0bad5f |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | CENPF BRCA2 ANLN BUB1 KCNMB4 KIF11 KNL1 TEX15 RUNX1T1 PKHD1L1 KIF20A SHCBP1 CDC6 | 6.30e-12 | 197 | 200 | 13 | 76b61e60a757e58b465569538e632d6d9953e89a |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | CENPF ZGRF1 BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A DDIAS SHCBP1 CDC6 | 6.30e-12 | 197 | 200 | 13 | 84ed777cdba569200a3ef1654d8a12f17fcfb7f1 |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | CENPF ZGRF1 BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A SHCBP1 CDC6 HELLS | 6.30e-12 | 197 | 200 | 13 | 8b616cde333bdbc0c591035ad9e4949155866245 |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_NK-Cycling_NK|lymph-node_spleen / Manually curated celltypes from each tissue | CENPF ZGRF1 BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A SHCBP1 CDC6 HELLS | 6.72e-12 | 198 | 200 | 13 | b2868a897dd96494cf1829c30e0ce508f52efdf3 |
| ToppCell | COVID-19_Moderate-T/NK_proliferative|World / disease group, cell group and cell class | CENPF ZGRF1 BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A SHCBP1 CDC6 HELLS | 6.72e-12 | 198 | 200 | 13 | bf0131fbca6032e1aab4aa807f8c1d3be689cb7f |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | CENPF ZGRF1 BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A SHCBP1 CDC6 HELLS | 6.72e-12 | 198 | 200 | 13 | bcfe7b6d91f2e2f145cb2660b65fd2a6c1134b86 |
| ToppCell | COVID-19_Moderate-T/NK_proliferative|COVID-19_Moderate / disease group, cell group and cell class | CENPF ZGRF1 BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A SHCBP1 CDC6 HELLS | 6.72e-12 | 198 | 200 | 13 | 166c000fb0e19602ffdd8bf2b2f19be2c6df96a6 |
| ToppCell | VE-cycling|VE / Condition, Cell_class and T cell subcluster | CENPF ITGA1 BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A SHCBP1 CDC6 HELLS | 7.16e-12 | 199 | 200 | 13 | 47c47ebc318a0b98841ca2656837bbd068899559 |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Proliferating-Cycling_Progenitors|6_mon / Sample Type, Dataset, Time_group, and Cell type. | CENPF BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A DDIAS SHCBP1 CDC6 HELLS | 7.16e-12 | 199 | 200 | 13 | a99516a5760f49a69b0fe45a9b2316e393252966 |
| ToppCell | VE-cycling-|VE / Condition, Cell_class and T cell subcluster | CENPF ITGA1 BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A SHCBP1 CDC6 HELLS | 7.16e-12 | 199 | 200 | 13 | c0a67149a19b65b3069dbc5261d81f658e6e39a2 |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-FOXM1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | CCP110 CENPF ZGRF1 BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A SHCBP1 CDC6 | 7.16e-12 | 199 | 200 | 13 | 98575fcce726589e93fbb4df1aab03e57cb56076 |
| ToppCell | healthy_donor-Lymphocytic-Proliferative_Lymphocyte|healthy_donor / Disease condition, Lineage, Cell class and subclass | CENPF BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A SHCBP1 KIF4B CDC6 HELLS | 7.63e-12 | 200 | 200 | 13 | e4eb915c29909cf8535a3603c68976545c05e54b |
| ToppCell | healthy_donor-Lymphocytic-Proliferative_Lymphocyte-|healthy_donor / Disease condition, Lineage, Cell class and subclass | CENPF BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A SHCBP1 KIF4B CDC6 HELLS | 7.63e-12 | 200 | 200 | 13 | 415e7556b5ac45688e2c6c30a52bd40e0eb27c7d |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Proliferating|6_mon / Sample Type, Dataset, Time_group, and Cell type. | CENPF BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A DDIAS SHCBP1 CDC6 HELLS | 7.63e-12 | 200 | 200 | 13 | 8f9e76048ae6f45218a09a95a2c4b31e8a8937b2 |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | CENPF ZGRF1 BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A DDIAS SHCBP1 | 1.15e-11 | 163 | 200 | 12 | 5285318c52aa31c9b22dc2ffff078e32e408604d |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-matrix_-_immature_4|E18.5-samps / Age Group, Lineage, Cell class and subclass | CENPF BRCA1 ANLN GPR149 BUB1 KIF11 KNL1 DDIAS SHCBP1 ZNF239 HELLS | 1.86e-11 | 130 | 200 | 11 | 169d88bffd7cd813a484d809defa638ceaca4bcb |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | CENPF ZGRF1 ITGA1 BRCA2 ANLN BUB1 KIF11 KNL1 ATP10A CDC6 ANO3 HELLS | 2.03e-11 | 171 | 200 | 12 | b0373ed8283ee1792b6a490bff93906546978593 |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | CENPF ZGRF1 ITGA1 BRCA2 ANLN BUB1 KIF11 KNL1 ATP10A CDC6 ANO3 HELLS | 2.03e-11 | 171 | 200 | 12 | b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55 |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | CENPF ZGRF1 BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A DDIAS SHCBP1 | 3.69e-11 | 180 | 200 | 12 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | CENPF ZGRF1 BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 KIF20A SHCBP1 CDC6 HELLS | 3.69e-11 | 180 | 200 | 12 | f8a15c13d85c1bbbf86ce49bb6f86c368ddf22df |
| ToppCell | Dividing_Macrophages-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | CENPF BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A SHCBP1 CDC6 HELLS | 4.78e-11 | 184 | 200 | 12 | f15ce786d25c6546804a6d1efcc2ad645f2ef54e |
| ToppCell | Bac-SEP-Lymphocyte-B-Plasmablast|Bac-SEP / Disease, Lineage and Cell Type | CENPF CADM1 ANLN BUB1 KIF11 PKHD1L1 SPAG5 KIF20A JCHAIN SHCBP1 CDC6 HELLS | 6.53e-11 | 189 | 200 | 12 | 6339b6d1056e07cefb0e1b2a0e479913c5783c8a |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | CENPF ZGRF1 BRCA1 BRCA2 ANLN STARD9 BUB1 KIF11 KNL1 ISLR2 KIF20A HELLS | 6.94e-11 | 190 | 200 | 12 | 31de1727822e9818652946dfb962daee77ffad68 |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | CENPF ZGRF1 BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 CEP192 CCDC77 SHCBP1 HELLS | 6.94e-11 | 190 | 200 | 12 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b |
| ToppCell | Int-URO-Lymphocyte-T_NK-T_NK_proliferative|Int-URO / Disease, Lineage and Cell Type | CENPF BRCA1 BRCA2 BUB1 KIF11 KNL1 SPAG5 KIF20A SHCBP1 KIF4B CDC6 HELLS | 6.94e-11 | 190 | 200 | 12 | 005967c540418b85311308072a07c684f4296aef |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | CENPF THAP10 BRCA1 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A SHCBP1 CDC6 HELLS | 7.38e-11 | 191 | 200 | 12 | 50854384fdaa0efa2e3227659d544ed09ac102f2 |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | CENPF ZGRF1 BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 CEP192 CCDC77 SHCBP1 HELLS | 8.32e-11 | 193 | 200 | 12 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f |
| ToppCell | human_hepatoblastoma-Tumor_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | KIZ TRIM24 SH3BP4 CADM1 ATF7IP2 MED13 TBX3 DSP COBLL1 PPP1R9A ARFGEF2 WDR59 | 8.32e-11 | 193 | 200 | 12 | 503a979328c68b096680b71359a26f02fafdff35 |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | CENPF BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A SHCBP1 CDC6 HELLS | 8.84e-11 | 194 | 200 | 12 | f39a471293ecc5c5967b00e772b8f48ebc9affbe |
| ToppCell | 3'_v3-Lung-Myeloid_Mac-Cycling_Myeloid-Mac|Lung / Manually curated celltypes from each tissue | CENPF BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A SHCBP1 CDC6 HELLS | 8.84e-11 | 194 | 200 | 12 | a8ae49157ca3f9e8b3f1750a995aee012dc859b6 |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | CENPF ZGRF1 BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A SHCBP1 CDC6 | 8.84e-11 | 194 | 200 | 12 | f9070035553bc68106a9e0bdf4b507715a138aba |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | CENPF BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A SHCBP1 CDC6 HELLS | 8.84e-11 | 194 | 200 | 12 | a75ecd0b0a928d4646602f7d16a645f6b3df3af5 |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | CENPF BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A SHCBP1 CDC6 HELLS | 8.84e-11 | 194 | 200 | 12 | 17744fd6645cf5a447a01a83f07e8d305c2bcd9c |
| ToppCell | PBMC-Mild-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | CENPF BRCA1 ANLN BUB1 KIF11 KNL1 PKHD1L1 SPAG5 KIF20A JCHAIN SHCBP1 CDC6 | 8.84e-11 | 194 | 200 | 12 | 5a519538327029ad2b880ef9647e2ac6ab3961a4 |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | CENPF BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A SHCBP1 CDC6 HELLS | 8.84e-11 | 194 | 200 | 12 | e14f66f7584909621b776292fbd52808273fd2ee |
| ToppCell | Control-Lymphoid_T/NK-T/NK_proliferative|Control / Disease group, lineage and cell class | CENPF BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A SHCBP1 CDC6 HELLS | 8.84e-11 | 194 | 200 | 12 | 9bbb124001fba7450f4639f47f9b720a483e7242 |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-J_(AT1-AT2_progenitors)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | CENPF BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A DDIAS SHCBP1 CDC6 HELLS | 8.84e-11 | 194 | 200 | 12 | 4d6ae2b25db11a4ae6dadee83be5c8c05b1225c3 |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | CENPF ZGRF1 BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A SHCBP1 CDC6 | 9.38e-11 | 195 | 200 | 12 | 926eb3fc5d028be936885bea0654a77db3107234 |
| ToppCell | Healthy/Control-T/NK_proliferative|Healthy/Control / Disease group and Cell class | CENPF BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A SHCBP1 CDC6 HELLS | 9.38e-11 | 195 | 200 | 12 | 957458fdc39723f4a31bd7fd3ce32891aa3fd462 |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | CENPF ZGRF1 BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A SHCBP1 CDC6 | 9.38e-11 | 195 | 200 | 12 | 1a5e814e12fe37287dbfc58189e1958e2c76b5da |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | CENPF ZGRF1 KCNQ5 BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SHCBP1 PCNT HELLS | 9.38e-11 | 195 | 200 | 12 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | CENPF BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 KIF20A SHCBP1 KIF4B CDC6 HELLS | 9.96e-11 | 196 | 200 | 12 | 9591a6a3477ed6a1e2e016f7542e38603d8b16cb |
| ToppCell | cycling_basal_cell|World / shred by cell class for nasal brushing | CENPF BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A SHCBP1 CDC6 HELLS | 9.96e-11 | 196 | 200 | 12 | aa7bac70a2fe4a3cb28d89fa1a87c68c2ead1349 |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | CENPF ZGRF1 BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A SHCBP1 CDC6 | 9.96e-11 | 196 | 200 | 12 | 1964c5003a0cb84539850a7cfe3bbb0e23a61d2d |
| ToppCell | mild-Lymphocytic-Prol._cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | CENPF BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A SHCBP1 CDC6 HELLS | 9.96e-11 | 196 | 200 | 12 | b1d9866d5dfaefdb8bedaf01a750d97987acb3d1 |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | CENPF ZGRF1 BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A SHCBP1 CDC6 | 9.96e-11 | 196 | 200 | 12 | 73f951f7712e0aa3323676b9a4b7944d21d347c4 |
| ToppCell | Control-T/NK_proliferative|Control / Disease condition and Cell class | CENPF BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A SHCBP1 CDC6 HELLS | 9.96e-11 | 196 | 200 | 12 | 7b7bc25aef49bfd64f79303a92d527bf8188f7a6 |
| ToppCell | proximal-Hematologic-Proliferating_Macrophage|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | CENPF RAB42 BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 SHCBP1 CDC6 HELLS | 1.06e-10 | 197 | 200 | 12 | 0b1fa881abbfcc54b322fc27124db3f8947af016 |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic-lymphocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | CENPF BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A SHCBP1 CDC6 HELLS | 1.06e-10 | 197 | 200 | 12 | 21861d8b389fafbdb7c3499684c9b6deee3dbd5e |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic-lymphocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | CENPF BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A SHCBP1 CDC6 HELLS | 1.06e-10 | 197 | 200 | 12 | ffb004c37cdd26cb7cdcd80f769a2eded65416dc |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | CENPF BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A SHCBP1 CDC6 HELLS | 1.06e-10 | 197 | 200 | 12 | 4b13335a43b9d6abc8e542e72440da7feb82fbe6 |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-T_NK_proliferative|ICU-SEP / Disease, Lineage and Cell Type | CENPF BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A SHCBP1 CDC6 HELLS | 1.06e-10 | 197 | 200 | 12 | 908e91fa16134b61943aea5e8fc0d6fbac8a8c6e |
| ToppCell | proximal-3-Hematologic-Proliferating_Macrophage|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | CENPF RAB42 BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 SHCBP1 CDC6 HELLS | 1.06e-10 | 197 | 200 | 12 | 0dd9058aa19d1268ebba9a65555870224b5a5978 |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / Treatment groups by lineage, cell group, cell type | CCP110 CENPF BRCA2 ANLN BUB1 KNL1 TBX3 SPAG5 KIF20A CCNB3 SHCBP1 CDC6 | 1.06e-10 | 197 | 200 | 12 | 038fd92750257d43d5e980fd06d77742b543f11a |
| ToppCell | proximal-Hematologic-Proliferating_Macrophage-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | CENPF RAB42 BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 SHCBP1 CDC6 HELLS | 1.06e-10 | 197 | 200 | 12 | 9243617b307acf3df40d93c41cd8d4788699a7ea |
| ToppCell | Healthy_donor-T/NK_proliferative|Healthy_donor / disease group, cell group and cell class (v2) | CENPF BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A SHCBP1 CDC6 HELLS | 1.06e-10 | 197 | 200 | 12 | b6bbf87e5823fa66b4cad6a7be4f777356887b59 |
| ToppCell | (0)_NK_cells-(0)_NK_Dividing|(0)_NK_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | CENPF BRCA1 BRCA2 ANLN KIF11 KNL1 SPAG5 KIF20A DDIAS SHCBP1 CDC6 HELLS | 1.12e-10 | 198 | 200 | 12 | d9cdbc7d420472cb1ffb36ad9c8e53a61b7dbdeb |
| ToppCell | MS-cycling-|MS / Condition, Cell_class and T cell subcluster | CENPF ANLN BUB1 KIF11 KNL1 PKHD1L1 SPAG5 KIF20A DDIAS JCHAIN SHCBP1 CDC6 | 1.12e-10 | 198 | 200 | 12 | 19c5d6b65de490118574b1f86b45c58b3a51df7f |
| ToppCell | distal-Hematologic-Proliferating_Macrophage-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | CENPF BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A SHCBP1 CDC6 HELLS | 1.12e-10 | 198 | 200 | 12 | 8afeb1f9bc9d8551482c8fefe4c5f88d9cd13ee2 |
| ToppCell | cycling_basal_cell|World / shred by cell class for turbinate | CENPF BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A SHCBP1 CDC6 HELLS | 1.12e-10 | 198 | 200 | 12 | e86c1224f5b0890a50a25257628e90c790aae7cd |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | CENPF BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A SHCBP1 CDC6 HELLS | 1.12e-10 | 198 | 200 | 12 | 48d39018c56ea8ba972c72af8ece10cbeb48fbc8 |
| ToppCell | medial-Hematologic-Proliferating_Macrophage|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | CENPF BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A SHCBP1 CDC6 HELLS | 1.12e-10 | 198 | 200 | 12 | da6963184c32761c896a9b91a5321ad84b583736 |
| ToppCell | medial-2-Hematologic-Proliferating_Macrophage|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | CENPF BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A SHCBP1 CDC6 HELLS | 1.12e-10 | 198 | 200 | 12 | 64a2bcf5a9ba66a4fe08fbde33f1886c136cde8f |
| ToppCell | medial-Hematologic-Proliferating_Macrophage-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | CENPF BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A SHCBP1 CDC6 HELLS | 1.12e-10 | 198 | 200 | 12 | fcc14ac3eb5088b9d6cd6af5a34dee5b81c0ece8 |
| ToppCell | MS-cycling|MS / Condition, Cell_class and T cell subcluster | CENPF ANLN BUB1 KIF11 KNL1 PKHD1L1 SPAG5 KIF20A DDIAS JCHAIN SHCBP1 CDC6 | 1.12e-10 | 198 | 200 | 12 | 0c22f2cc0e5ca91cabcd4aac2b9ef05af47e967f |
| ToppCell | (0)_NK_dividing|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | CENPF BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A SHCBP1 CDC6 HELLS | 1.12e-10 | 198 | 200 | 12 | c5336d9b802393d6fd6f8446ea4bb6befeb97bfd |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | CENPF ZGRF1 BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 SHCBP1 CDC6 HELLS | 1.19e-10 | 199 | 200 | 12 | 11c3d9fe811a4619347f47d2b0e94066e3085625 |
| ToppCell | 367C-Myeloid-Dendritic-cDC_proliferating_1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | CENPF ZGRF1 BRCA1 ANLN BUB1 KNL1 SPAG5 KIF20A SHCBP1 RAI14 CDC6 HELLS | 1.19e-10 | 199 | 200 | 12 | 3d876f172487425b37b2f658dae59e0f293ee76e |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-T_NK_proliferative|Leuk-UTI / Disease, Lineage and Cell Type | CENPF BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A SHCBP1 CDC6 HELLS | 1.19e-10 | 199 | 200 | 12 | 87113d398585076ece86b9098781e817f8ca241b |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | CENPF ZGRF1 BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 SHCBP1 CDC6 HELLS | 1.19e-10 | 199 | 200 | 12 | 36c80907b2ec1cbcd1b4e841e6c02a4792591d74 |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | CENPF ZGRF1 BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 SHCBP1 CDC6 HELLS | 1.19e-10 | 199 | 200 | 12 | bf4c31902ae8358215245a2e11b5a2fe4ca1bc8c |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | CENPF BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A SHCBP1 CDC6 HELLS | 1.19e-10 | 199 | 200 | 12 | 4af38f5e9d2229d64f7ecdf9c00b4d67e5f86a51 |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | CENPF ZGRF1 BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 SHCBP1 CDC6 HELLS | 1.19e-10 | 199 | 200 | 12 | 7beb0e07a27fea94674f24eb61c381b0de38ed3e |
| ToppCell | critical-Lymphoid-NKT-proliferating|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | CENPF BRCA1 ANLN BUB1 KIF11 KNL1 DSP PSCA SPAG5 KIF20A SHCBP1 CDC6 | 1.19e-10 | 199 | 200 | 12 | 9284956d852e434a91be892e88e06a7c71f8c583 |
| ToppCell | Mild-T/NK_proliferative|Mild / Disease group and Cell class | CENPF BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A SHCBP1 CDC6 HELLS | 1.19e-10 | 199 | 200 | 12 | 64a5c91243ee999ea21ffddd450d3e5fdbf6470b |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-T/NK_proliferative|COVID-19_Mild / Disease group, lineage and cell class | CENPF ZGRF1 BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 SHCBP1 CDC6 HELLS | 1.19e-10 | 199 | 200 | 12 | ddea0e5c1cb6a096ab8e09a8c3c37c1bff381d9c |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_NK-Cycling_NK|bone_marrow / Manually curated celltypes from each tissue | CENPF BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A SHCBP1 CDC6 HELLS | 1.19e-10 | 199 | 200 | 12 | 6321140a1ebc1ff793fb6221a31e884368e42fa5 |
| ToppCell | (1)_T_cells-(1)_T_cell_dividing|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | CENPF BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A SHCBP1 CDC6 HELLS | 1.19e-10 | 199 | 200 | 12 | 33afdd1b1b951b360ababf440bc556fd9e1c1db2 |
| ToppCell | distal-Hematologic-Proliferating_Macrophage|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | CENPF BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A SHCBP1 CDC6 HELLS | 1.26e-10 | 200 | 200 | 12 | 3835a8a9739b8cd5bf19c40765ef76907ac1ad38 |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Stem_cells-Neuroepithelial_cell|3m / Sample Type, Dataset, Time_group, and Cell type. | CENPF BRCA1 BRCA2 GLI3 BUB1 KIF11 KNL1 SPAG5 KIF20A SHCBP1 CDC6 HELLS | 1.26e-10 | 200 | 200 | 12 | 2938a029fa0478be561574ace91f95c4a528b2d4 |
| ToppCell | distal-2-Hematologic-Proliferating_Macrophage|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | CENPF BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A SHCBP1 CDC6 HELLS | 1.26e-10 | 200 | 200 | 12 | 0cd3b01fb7f579e5abf000adb8ec8adc7cd779c4 |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Stem_cells|GW19 / Sample Type, Dataset, Time_group, and Cell type. | CENPF BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 AKAP12 SPAG5 KIF20A SHCBP1 PRKD1 | 1.26e-10 | 200 | 200 | 12 | 31dd81df9aa754a1e69b905bf9b8ce73ff8175aa |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells-Neuroepithelial_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | CENPF BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A SHCBP1 CDC6 HELLS | 1.26e-10 | 200 | 200 | 12 | 0d9b8d51a7630e70e60c76c763ff82df4c559152 |
| ToppCell | NS-moderate-d_07-13-Lymphoid-NKT-proliferating|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | CENPF BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A SHCBP1 CDC6 HELLS | 1.26e-10 | 200 | 200 | 12 | 87e293c0882e2754756a2210a6c04723dc89f81b |
| ToppCell | control-T/NK_proliferative|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | CENPF BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A SHCBP1 CDC6 HELLS | 1.26e-10 | 200 | 200 | 12 | 1da366e35a05f73253629663eeea1fed4ebd7b52 |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Stem_cells-Neuroepithelial_cell|GW19 / Sample Type, Dataset, Time_group, and Cell type. | CENPF BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 AKAP12 SPAG5 KIF20A SHCBP1 PRKD1 | 1.26e-10 | 200 | 200 | 12 | 54174a485a82480726fa06efa6e050ddea77cb3c |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.12e-06 | 49 | 121 | 7 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Computational | Neighborhood of CDC20 | 3.68e-05 | 56 | 121 | 6 | GNF2_CDC20 | |
| Computational | Neighborhood of CCNB2 | 4.08e-05 | 57 | 121 | 6 | GNF2_CCNB2 | |
| Computational | Neighborhood of HMMR | 1.75e-04 | 47 | 121 | 5 | GNF2_HMMR | |
| Computational | Neighborhood of BUB1B | 2.14e-04 | 49 | 121 | 5 | GNF2_BUB1B | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.35e-04 | 50 | 121 | 5 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Computational | Neighborhood of ESPL1 | 6.11e-04 | 35 | 121 | 4 | GNF2_ESPL1 | |
| Computational | Spindle and kinetochore. | 7.00e-04 | 16 | 121 | 3 | MODULE_315 | |
| Drug | Lucanthone | CENPF BRCA1 BRCA2 ANLN BUB1 KIF11 KNL1 SPAG5 KIF20A SHCBP1 KIF4B CDC6 | 3.89e-07 | 212 | 199 | 12 | ctd:D008154 |
| Drug | nocodazole | MYH3 CEP350 PTK2B BUB1 GOLGA4 KIF11 RBBP6 APC ARFGEF2 AKAP12 GLMN AKAP9 CCNB3 CD40 CDC6 PCNT | 4.99e-06 | 477 | 199 | 16 | CID000004122 |
| Disease | MONILETHRIX | 2.89e-07 | 3 | 196 | 3 | 158000 | |
| Disease | Beaded hair | 2.89e-07 | 3 | 196 | 3 | cv:C0546966 | |
| Disease | monilethrix (is_implicated_in) | 2.89e-07 | 3 | 196 | 3 | DOID:0050472 (is_implicated_in) | |
| Disease | Monilethrix | 1.15e-06 | 4 | 196 | 3 | C0546966 | |
| Disease | Mammary Carcinoma, Human | CENPF BCL2A1 GALNT16 CADM1 BRCA1 BRCA2 AFP ALDOA TBX3 SYNE1 DLL1 AKAP12 CD40 NCOA1 TP53BP1 | 2.61e-06 | 525 | 196 | 15 | C4704874 |
| Disease | Mammary Neoplasms, Human | CENPF BCL2A1 GALNT16 CADM1 BRCA1 BRCA2 AFP ALDOA TBX3 SYNE1 DLL1 AKAP12 CD40 NCOA1 TP53BP1 | 2.61e-06 | 525 | 196 | 15 | C1257931 |
| Disease | Mammary Neoplasms | CENPF BCL2A1 GALNT16 CADM1 BRCA1 BRCA2 AFP ALDOA TBX3 SYNE1 DLL1 AKAP12 CD40 NCOA1 TP53BP1 | 2.73e-06 | 527 | 196 | 15 | C1458155 |
| Disease | Malignant neoplasm of breast | CENPF OBSCN BCL2A1 GALNT16 CADM1 BRCA1 BRCA2 AFP POP1 ALDOA TBX3 SYNE1 ARFGEF2 DLL1 AKAP12 RIF1 AKAP9 N4BP2 CD40 NCOA1 VPS13B TP53BP1 | 3.07e-06 | 1074 | 196 | 22 | C0006142 |
| Disease | Breast Carcinoma | CENPF BCL2A1 GALNT16 CADM1 BRCA1 BRCA2 AFP ALDOA TBX3 SYNE1 DLL1 AKAP12 CD40 NCOA1 TP53BP1 | 3.51e-06 | 538 | 196 | 15 | C0678222 |
| Disease | Colorectal Carcinoma | TET2 OBSCN KCNQ5 GLI3 BUB1 ETAA1 PHIP SYNE1 APC RUNX1T1 LGR5 SLC1A7 AKAP12 AKAP9 CCNB3 PRKD1 ZNF292 | 5.09e-06 | 702 | 196 | 17 | C0009402 |
| Disease | body weight | TET2 HIVEP2 KIZ RABGAP1 TRIM24 ADCY9 BTN2A2 CADM1 KCNQ5 ANLN LRFN5 ULK4 PLCL1 LCORL HECTD4 PSCA CEP192 RUNX1T1 CGGBP1 WDR59 CTNNA3 PRKD1 CCDC171 | 1.20e-05 | 1261 | 196 | 23 | EFO_0004338 |
| Disease | ductal carcinoma in situ (biomarker_via_orthology) | 4.39e-05 | 2 | 196 | 2 | DOID:0060074 (biomarker_via_orthology) | |
| Disease | Hereditary site-specific ovarian cancer syndrome | 4.39e-05 | 2 | 196 | 2 | C4749652 | |
| Disease | hair disease (is_implicated_in) | 4.39e-05 | 2 | 196 | 2 | DOID:421 (is_implicated_in) | |
| Disease | Prostatic Neoplasms | TET2 CENPF BRCA1 BRCA2 KMT2A GOLGA4 PMS1 TBX3 PSCA APC CLDN3 PPL NCOA1 ZNF292 | 7.01e-05 | 616 | 196 | 14 | C0033578 |
| Disease | Malignant neoplasm of prostate | TET2 CENPF BRCA1 BRCA2 KMT2A GOLGA4 PMS1 TBX3 PSCA APC CLDN3 PPL NCOA1 ZNF292 | 7.01e-05 | 616 | 196 | 14 | C0376358 |
| Disease | Benign tumor of pancreas | 7.86e-05 | 13 | 196 | 3 | C0347284 | |
| Disease | serum gamma-glutamyl transferase measurement | ZC3H11B ITGA1 ITGB2 KDM2B KMT2A MED13 GOLGA4 LCORL COBLL1 HECTD4 TLN1 CGNL1 CSMD1 CCDC171 ALPK2 TP53BP1 ZNF292 | 1.39e-04 | 914 | 196 | 17 | EFO_0004532 |
| Disease | coronary artery disease | TET2 HIVEP2 ITGA1 DMXL1 GPR149 PLCL1 MARCHF1 DNAJC13 LCORL DOCK8 PPP1R9A HECTD4 ARFGEF2 RNF213 DUOX2 TRIM5 AKAP12 GLMN KIF4B TNKS | 1.46e-04 | 1194 | 196 | 20 | EFO_0001645 |
| Disease | Liver carcinoma | CENPF TRIM24 GPR158 ANLN AFP BUB1 KMT2A KIF11 APC KIF20A CDC6 CSMD1 | 1.60e-04 | 507 | 196 | 12 | C2239176 |
| Disease | smoking behavior, BMI-adjusted waist circumference | 1.70e-04 | 122 | 196 | 6 | EFO_0004318, EFO_0007789 | |
| Disease | Intellectual Disability | HIVEP2 KCNQ5 BRCA1 PHIP MED13 DOCK8 SYNE1 APC DLL1 LINS1 ZNF292 | 2.15e-04 | 447 | 196 | 11 | C3714756 |
| Disease | Chronic myeloproliferative disorder | 2.59e-04 | 19 | 196 | 3 | C1292778 | |
| Disease | Pancreatic carcinoma | 2.59e-04 | 19 | 196 | 3 | C0235974 | |
| Disease | Hereditary breast ovarian cancer syndrome | 2.61e-04 | 4 | 196 | 2 | cv:C0677776 | |
| Disease | breast adenocarcinoma (is_implicated_in) | 2.61e-04 | 4 | 196 | 2 | DOID:3458 (is_implicated_in) | |
| Disease | red blood cell density measurement | TET2 ZC3H11B ITGA1 PRKD3 ULK4 KIF11 KLF11 COBLL1 ARFGEF2 NCOA4 CGGBP1 KIF4B RAI14 CGNL1 MYO16 VPS13B | 2.81e-04 | 880 | 196 | 16 | EFO_0007978 |
| Disease | cataract | 3.71e-04 | 141 | 196 | 6 | MONDO_0005129 | |
| Disease | Seckel syndrome | 4.05e-04 | 22 | 196 | 3 | C0265202 | |
| Disease | hereditary breast ovarian cancer syndrome (is_implicated_in) | 4.33e-04 | 5 | 196 | 2 | DOID:5683 (is_implicated_in) | |
| Disease | C-reactive protein measurement | ZNF536 CCDC168 ITGA1 ADCY9 GATAD2B HSF5 USP44 RNF10 KDM2B LCORL COBLL1 CEP192 PPL GLMN SETD5 TNKS CCDC171 CEACAM20 TP53BP1 | 4.59e-04 | 1206 | 196 | 19 | EFO_0004458 |
| Disease | Metastatic melanoma | 4.61e-04 | 54 | 196 | 4 | C0278883 | |
| Disease | sensory peripheral neuropathy, remission | 4.63e-04 | 23 | 196 | 3 | EFO_0009785, MONDO_0002321 | |
| Disease | breast cancer (implicated_via_orthology) | 5.96e-04 | 25 | 196 | 3 | DOID:1612 (implicated_via_orthology) | |
| Disease | cognitive function measurement | ZNF536 AFTPH GALNT16 GATAD2B GLI3 RNF10 PLCL1 MARCHF1 LCORL DSP SLC35B3 MAP3K14 COPG2 CEP192 RUNX1T1 GLMN LRRC53 CD40 CTNNA3 TNKS PRKD1 | 5.98e-04 | 1434 | 196 | 21 | EFO_0008354 |
| Disease | Malignant neoplasm of pancreas | 6.08e-04 | 102 | 196 | 5 | C0346647 | |
| Disease | prostate cancer (is_marker_for) | 6.33e-04 | 156 | 196 | 6 | DOID:10283 (is_marker_for) | |
| Disease | unipolar depression, bipolar disorder | 6.33e-04 | 156 | 196 | 6 | EFO_0003761, MONDO_0004985 | |
| Disease | Adult only | 6.47e-04 | 6 | 196 | 2 | C3842001 | |
| Disease | Colorectal cancer | 7.51e-04 | 27 | 196 | 3 | cv:C0346629 | |
| Disease | COLORECTAL CANCER | 7.51e-04 | 27 | 196 | 3 | 114500 | |
| Disease | Neoplasm of the large intestine | 7.51e-04 | 27 | 196 | 3 | cv:C0009404 | |
| Disease | blood manganese measurement | 7.51e-04 | 27 | 196 | 3 | EFO_0007581 | |
| Disease | Hereditary Diffuse Gastric Cancer | 8.04e-04 | 293 | 196 | 8 | C1708349 | |
| Disease | Stomach Neoplasms | 8.78e-04 | 297 | 196 | 8 | C0038356 | |
| Disease | Neoplasm of uncertain or unknown behavior of ovary | 9.29e-04 | 29 | 196 | 3 | C0496920 | |
| Disease | Malignant neoplasm of stomach | 9.36e-04 | 300 | 196 | 8 | C0024623 | |
| Disease | Ovarian Carcinoma | 1.03e-03 | 30 | 196 | 3 | C0029925 | |
| Disease | MYELODYSPLASTIC SYNDROME | 1.04e-03 | 67 | 196 | 4 | C3463824 | |
| Disease | lung disease severity measurement | 1.17e-03 | 118 | 196 | 5 | EFO_0007744 | |
| Disease | obesity | 1.19e-03 | 241 | 196 | 7 | EFO_0001073 | |
| Disease | Cornelia De Lange Syndrome | 1.20e-03 | 8 | 196 | 2 | C0270972 | |
| Disease | lower urinary tract symptom, benign prostatic hyperplasia | 1.24e-03 | 32 | 196 | 3 | EFO_0000284, EFO_0008008 | |
| Disease | colorectal cancer (is_implicated_in) | 1.31e-03 | 121 | 196 | 5 | DOID:9256 (is_implicated_in) | |
| Disease | Brain Tumor, Primary | 1.36e-03 | 33 | 196 | 3 | C0750974 | |
| Disease | Primary malignant neoplasm of brain | 1.36e-03 | 33 | 196 | 3 | C0750979 | |
| Disease | Recurrent Brain Neoplasm | 1.36e-03 | 33 | 196 | 3 | C0750977 | |
| Disease | Benign neoplasm of brain, unspecified | 1.36e-03 | 33 | 196 | 3 | C0496899 | |
| Disease | Neoplasms, Intracranial | 1.36e-03 | 33 | 196 | 3 | C1527390 | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 40 | 1.53e-03 | 9 | 196 | 2 | C4225275 | |
| Disease | primary bacterial infectious disease (implicated_via_orthology) | 1.53e-03 | 9 | 196 | 2 | DOID:0050338 (implicated_via_orthology) | |
| Disease | Pancreatic carcinoma, familial | 1.53e-03 | 9 | 196 | 2 | C2931038 | |
| Disease | vital capacity | TET2 HIVEP2 ZSWIM2 TRIM24 TRIP11 KCNQ5 GLI3 PLCL1 LCORL DSP CEP162 SYNE1 MAP3K14 ARFGEF2 CTNNA3 NCOA1 CCDC171 MYO16 | 1.57e-03 | 1236 | 196 | 18 | EFO_0004312 |
| Disease | Disproportionate short stature | 1.75e-03 | 77 | 196 | 4 | C0878659 | |
| Disease | risk-taking behaviour | TET2 ZNF536 ACTR10 TMEM132B LRFN5 ALDOA LCORL TRIM39 RUNX1T1 DLL1 CD40 TNKS CCDC171 | 1.88e-03 | 764 | 196 | 13 | EFO_0008579 |
| Disease | medulloblastoma (is_implicated_in) | 1.91e-03 | 10 | 196 | 2 | DOID:0050902 (is_implicated_in) | |
| Disease | postburn hypertrophic scarring severity measurement | 1.91e-03 | 10 | 196 | 2 | EFO_0007747 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 1.91e-03 | 10 | 196 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 1.91e-03 | 10 | 196 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | glucagon-like peptide-1 measurement | 1.91e-03 | 10 | 196 | 2 | EFO_0008465 | |
| Disease | nephritis (implicated_via_orthology) | 1.91e-03 | 10 | 196 | 2 | DOID:10952 (implicated_via_orthology) | |
| Disease | Fanconi anemia (is_implicated_in) | 1.91e-03 | 10 | 196 | 2 | DOID:13636 (is_implicated_in) | |
| Disease | Malignant neoplasm of brain | 2.05e-03 | 38 | 196 | 3 | C0153633 | |
| Disease | phosphatidylcholine 32:1 measurement | 2.05e-03 | 38 | 196 | 3 | EFO_0010373 | |
| Disease | comparative body size at age 10, self-reported | 2.08e-03 | 420 | 196 | 9 | EFO_0009819 | |
| Disease | Brain Neoplasms | 2.21e-03 | 39 | 196 | 3 | C0006118 | |
| Disease | cerebral cavernous malformation (implicated_via_orthology) | 2.32e-03 | 11 | 196 | 2 | DOID:0060669 (implicated_via_orthology) | |
| Disease | Congenital long QT syndrome | 2.32e-03 | 11 | 196 | 2 | cv:C1141890 | |
| Disease | waist-hip ratio, sexual dimorphism | 2.32e-03 | 11 | 196 | 2 | EFO_0004343, EFO_0005951 | |
| Disease | Umbilical hernia | 2.32e-03 | 11 | 196 | 2 | HP_0001537 | |
| Disease | waist circumference | 2.40e-03 | 429 | 196 | 9 | EFO_0004342 | |
| Disease | cup-to-disc ratio measurement | 2.44e-03 | 430 | 196 | 9 | EFO_0006939 | |
| Disease | grip strength measurement | 2.46e-03 | 350 | 196 | 8 | EFO_0006941 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 2.56e-03 | 41 | 196 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 2.56e-03 | 41 | 196 | 3 | C0858252 | |
| Disease | Colorectal Neoplasms | 2.62e-03 | 277 | 196 | 7 | C0009404 | |
| Disease | facial height measurement | 2.64e-03 | 142 | 196 | 5 | EFO_0007856 | |
| Disease | response to diuretic, high density lipoprotein cholesterol measurement | 2.77e-03 | 12 | 196 | 2 | EFO_0004612, GO_0036270 | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 2.77e-03 | 12 | 196 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | Long QT syndrome | 2.77e-03 | 12 | 196 | 2 | cv:C0023976 | |
| Disease | cleft lip | 3.01e-03 | 284 | 196 | 7 | EFO_0003959 | |
| Disease | electrocardiography | OBSCN PTPN12 CTAGE1 SCN5A RNF10 PLCL1 GRK7 LGR5 USP40 CTNNA3 | 3.01e-03 | 530 | 196 | 10 | EFO_0004327 |
| Disease | Thromboembolism | 3.13e-03 | 44 | 196 | 3 | HP_0001907 | |
| Disease | illegal drug consumption | 3.26e-03 | 13 | 196 | 2 | EFO_0005431 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 3.34e-03 | 45 | 196 | 3 | DOID:3748 (is_implicated_in) | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 3.34e-03 | 150 | 196 | 5 | EFO_0004611, EFO_0020947 | |
| Disease | Neurodevelopmental Disorders | 3.48e-03 | 93 | 196 | 4 | C1535926 | |
| Disease | response to 5-fluorouracil, response to cyclophosphamide, chemotherapy-induced alopecia, response to doxorubicin | 3.79e-03 | 14 | 196 | 2 | EFO_0005400, GO_0036275, GO_1902518, GO_1902520 | |
| Disease | Hereditary Breast and Ovarian Cancer Syndrome | 3.79e-03 | 14 | 196 | 2 | C0677776 | |
| Disease | obsolete_red blood cell distribution width | TNFRSF25 ADCY9 KSR1 GPR158 ANLN CTAGE1 RNF10 KDM2B KNL1 DNAJC13 DOCK8 HECTD4 DUOX2 NCOA4 TRIM5 RESF1 MYO16 HELLS | 3.93e-03 | 1347 | 196 | 18 | EFO_0005192 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VVRQQCSSAAEDLQK | 421 | Q96CN4 | |
| CSSAAEDLQKAQSTI | 426 | Q96CN4 | |
| CSADDQSTKAIDIQN | 786 | P53355 | |
| AENVQSCDTQVSSLL | 1006 | Q99996 | |
| SSQEAQLQQADICDT | 461 | Q7Z695 | |
| KCSQDQGVLASELAQ | 126 | Q9H6F5 | |
| ENVVAKQCTQATLDS | 626 | O43683 | |
| KLESSQQATAVCQED | 2526 | Q96PZ7 | |
| ATEAQSLEATCEKLN | 91 | Q96RT6 | |
| DTSAIKVNQVQEKSC | 476 | A6NCI8 | |
| ECAISTQAEQEAKTL | 601 | Q86TB3 | |
| GQEEAVCTKIQVQSS | 1401 | Q02952 | |
| KQTSDNLSEECQLAR | 501 | Q6ULP2 | |
| SEEEASINLNAINKC | 276 | P04075 | |
| SVDLTCQTVNQSVNV | 271 | Q6UY09 | |
| LCAQNSELQAKTNET | 116 | Q6TFL3 | |
| VKQDNEQLARSGTNC | 1436 | Q9Y6D5 | |
| KTIQAVGECEQSESS | 176 | Q9BR77 | |
| LTAQDITECNSNKEN | 66 | Q9ULD4 | |
| NLKSCLDNVNVVSVD | 51 | Q16548 | |
| QCNSTAQTEKVSVIQ | 91 | Q9UFW8 | |
| SCQNTVFKSVEELEN | 1586 | Q9UKL3 | |
| LNIEECSLTQQNKST | 676 | Q9Y485 | |
| NLSDSKVEECVQTSN | 621 | Q53SF7 | |
| KVEECVQTSNNNIST | 626 | Q53SF7 | |
| EQCTVDTSVAKEQSL | 181 | Q9NZ32 | |
| EVITLNATSQEACAA | 911 | O60312 | |
| KQSCQEESLAVQDVN | 241 | Q8WWL7 | |
| VNTEENKNDSVLRCS | 81 | Q9BYT9 | |
| NSQVSQEICKATEVF | 426 | Q9BYT9 | |
| AQLVTSKCQADAQAQ | 536 | Q8N428 | |
| LAACSLVESQSKANQ | 696 | Q6UXK2 | |
| LVCLNNTEISENSSD | 466 | Q9P0K7 | |
| VKCASNVEDNRVNSG | 226 | Q6ZP01 | |
| VETSVKNNCNVDLAF | 156 | Q8N4Z0 | |
| STKAEAVAAVQRQCQ | 66 | Q9H5N1 | |
| ATICNASIVLQNDNA | 151 | Q7Z3Y9 | |
| QCCKATSDNVIQSSE | 601 | Q96NI6 | |
| CSQLSERLEKQQTAN | 941 | Q9Y3P9 | |
| ENSSSTNLCVEDLQK | 161 | Q9NRZ9 | |
| SVSISVSNCQIQENV | 561 | Q15139 | |
| QQDLSNTTSKREECL | 676 | P10071 | |
| DVESTEQCLANSKQT | 636 | Q8NG48 | |
| TCSNEEKDNLNESVI | 761 | Q9NVR5 | |
| ALAVINQQEDSSESC | 501 | Q06455 | |
| DATKGLCKQQSQDSI | 366 | Q9Y6X6 | |
| QQAASEKESCITQLK | 1331 | Q13439 | |
| VDINLQKVDIDQCSS | 306 | Q5T848 | |
| SLVESQKQCGNLTED | 696 | P52732 | |
| KINTVCSADFLQQSE | 761 | A6NM62 | |
| CSDNTEVEVSNLENK | 71 | Q9NQW6 | |
| TTCLVASKENVQVAQ | 781 | Q9NR82 | |
| ELSSQGQSNTDKIEC | 116 | Q8N3X6 | |
| CQNSKLEAAVAQSEQ | 341 | O43790 | |
| CNTEAQGVQESLSKL | 631 | Q14164 | |
| SNNCLSKAQLAEVVE | 891 | Q9NRD8 | |
| KCAVSNDLTQQEIRT | 61 | Q8IVT5 | |
| EVEQNLQAAKQCSST | 671 | O60437 | |
| AQKEDIVLNSQNCIS | 156 | P21128 | |
| NDTTQNLLTKAVETC | 106 | Q8IXT1 | |
| AKQTSNCVLEICAEQ | 606 | P55160 | |
| SISVSNCQIQENVDI | 556 | O94806 | |
| CTLEKAQVESCQLNN | 1291 | Q8NG31 | |
| SSSEQLQSCQAEIIE | 301 | Q92764 | |
| EVVQSVIDSQGKSCA | 396 | Q8WXI9 | |
| ISNTLKEDQAANTSC | 106 | Q9Y4D8 | |
| EAIQKDSCESNHNIT | 871 | P56199 | |
| KTKENVNATENCISA | 961 | O00410 | |
| SCVVQTSNDTQCLNK | 206 | Q2M2Z5 | |
| ENNTEIVCSDLNKTE | 91 | Q9BZM2 | |
| VIKNQAIDACDANTT | 2141 | O95613 | |
| NFSCNVNTDIKDAVV | 251 | Q8TCQ1 | |
| VVSNDNKECLQLDTN | 66 | Q9Y5F1 | |
| AADCDLQITNAQTKE | 41 | Q7Z6E9 | |
| TVAQLDVCSDESVAQ | 61 | Q9NYR8 | |
| QDEIQNCIVTSNLTK | 491 | Q9NY74 | |
| KTSESICEINNNSEH | 631 | Q9NY74 | |
| NKCTNTDITEAKQDS | 471 | Q86SP6 | |
| AIATLSCEVAQAQTE | 1366 | Q5VST9 | |
| LECTQNKDLANQVSV | 106 | Q13772 | |
| QDICKSVTENKISDQ | 556 | Q99575 | |
| IVDCNVTDTKDNTNL | 246 | Q9HB29 | |
| FQVKVTATECIQEQS | 411 | P05107 | |
| SLNDCSNQVILAKAS | 1266 | P38398 | |
| EGEVATISCQVNKSD | 56 | Q9BY67 | |
| TISCQVNKSDDSVIQ | 61 | Q9BY67 | |
| ASKDTVCEEIQNALN | 236 | Q9UI47 | |
| NDEAKVFISVNCLST | 366 | Q9NZI5 | |
| TEINLSDCNKVTDQC | 1271 | Q8NHM5 | |
| VKEAQNLQCAASTAQ | 236 | Q9Y426 | |
| QENIIQASSALDCKD | 1441 | Q8NF50 | |
| AQQNGCVKSVAEASE | 506 | O00341 | |
| DVLSSDVQKNALAAC | 621 | O15228 | |
| DSLASTTDICQAKQA | 71 | Q13145 | |
| NSNQAVAVTFTKCEE | 2461 | P51587 | |
| CKSELERSQQAAQSA | 121 | P49454 | |
| KLTEDLSCQRQNAES | 366 | P49454 | |
| LETQVAHLCSQQSKQ | 2881 | P49454 | |
| QACNSTSEVKDLLEQ | 601 | Q0VF96 | |
| NNLANCQREKDISVS | 591 | O00548 | |
| ALEASNRIQESKNQC | 1791 | P15924 | |
| SKNQCTQVVQERESL | 1801 | P15924 | |
| CSQKVVVYDQSSQDV | 81 | Q9BY84 | |
| VLQEATCKIAAQQSE | 1426 | Q5VT06 | |
| QEEKLTNSQTSLCEI | 681 | O60503 | |
| QQVAAVDQSECLSLS | 496 | Q99741 | |
| EKLLCQNAVENSSSK | 1231 | Q5TB80 | |
| EDVVLGKSNQVCQSS | 451 | O43303 | |
| DCTNTLNDQLLEKVT | 661 | Q9UBF2 | |
| TSNQDCVNNIAESMV | 1801 | O75165 | |
| VNSVTSNNCADDILK | 236 | Q5U623 | |
| TAKLCDVAQQRNSED | 301 | Q5TF58 | |
| ENNSAVVDVKTCSID | 871 | Q8TEP8 | |
| QNECVSEISNSEKHV | 936 | Q8TEP8 | |
| SASEKEQQLVSTLQC | 951 | Q2VIQ3 | |
| DLQATEANCTVLSVQ | 46 | Q86W47 | |
| QVTDSKACTATDVLQ | 126 | O14901 | |
| QDTASVEQSSQKECG | 3591 | Q03164 | |
| QTVEEEALIKNNNTC | 251 | Q9UH77 | |
| LDNQIVTATQSNICD | 101 | P01591 | |
| TELDTSQQKTCQEQE | 3006 | Q8NDH2 | |
| QQNAVTSLSEECKRQ | 961 | Q14289 | |
| LSQAVATKCQAATTE | 126 | Q8WTQ7 | |
| VSCSVNNTLLGQEKE | 221 | Q8WVV5 | |
| SSKEEVIQQLSNLEC | 271 | A5D8W1 | |
| VASLQSDIIESQACQ | 796 | A5D8W1 | |
| SCKAQVSNEDCLQVE | 16 | O43653 | |
| LETNQKEVTASCDLS | 561 | Q9NQ36 | |
| CSSEISNIDKNTKNA | 421 | P54277 | |
| KNISVASCNSSQVVV | 496 | Q16531 | |
| ENAVECFQTKAATVT | 196 | P02771 | |
| CQNSKLEAAVAQSEQ | 346 | P78385 | |
| DVEKQSCDSTQALVT | 856 | O75473 | |
| VESECVLNQQVSLNS | 646 | Q5THK1 | |
| AAISIIAQAECENSQ | 76 | Q99558 | |
| VASNLQECVAQSSEE | 1026 | Q6ZN16 | |
| NSQEAQKSKDLCSIT | 526 | Q92990 | |
| CNNEAKDVSSIIVAF | 66 | Q5VXT5 | |
| DANIKCQTSSRENIL | 516 | Q4G112 | |
| TAAALENLQVEASCS | 16 | Q9HCM9 | |
| QVSAQLEECKGQTEQ | 696 | Q96R06 | |
| CAEKEAATSELQSIQ | 711 | O15119 | |
| QTQAVETNIVCKLDS | 311 | Q9P0V3 | |
| AVSQLCSKTQASLQE | 2391 | Q8NF91 | |
| ANTQVLQVSEACDAV | 446 | Q24JP5 | |
| DVIKVSNNCDSIFVN | 471 | Q14DG7 | |
| LNKQVVSSSEQLQSC | 296 | O76011 | |
| VSSSEQLQSCQAEII | 301 | O76011 | |
| ALVEQKVCSAQDVAS | 346 | P0C2Y1 | |
| DIQQEITVLSQCDSS | 66 | Q9P289 | |
| KQDESNTVICQDSTV | 1621 | Q5UIP0 | |
| NVTVEGNACKVTESN | 1896 | Q5UIP0 | |
| SVCSLQNQLAENAKA | 796 | Q9HCM1 | |
| SAVTICDELKIQSQN | 441 | Q9P2J5 | |
| VTAINQSKSEDQCIS | 896 | Q15788 | |
| SQNSCVDCSVTQSNK | 491 | Q05209 | |
| TIVNNKSQCESLNLT | 1376 | Q14524 | |
| DTINKTELACNNTVI | 251 | Q9C0A6 | |
| QETNKNNSESIECSK | 16 | Q9H1N7 | |
| SEEQVEAVNAKCASL | 1401 | P11055 | |
| QNCTDIKVEQLLASS | 561 | Q13017 | |
| NCEIVNELIAASTQK | 611 | Q8NEM2 | |
| CKQIDQSSSDQTRNE | 2596 | Q9P2P6 | |
| QIKNQCLSAIASDAE | 676 | Q9UHV7 | |
| AATCKVSSINQETIQ | 1246 | P25054 | |
| AQCTNCVQDDTAKAK | 101 | O15551 | |
| LEQEDSVVTNCIKTN | 1126 | Q9BXT8 | |
| NNISCAVISEDKRQV | 306 | Q9C035 | |
| EKCIIEAVSSACQSQ | 996 | Q63HN8 | |
| DVDQITLCSKCFQSQ | 31 | Q8N7C3 | |
| ACAVDSSEEQKQTAA | 621 | Q32MQ0 | |
| SSEEQKQTAAVALCQ | 626 | Q32MQ0 | |
| CSEQRTKTVQQNSDN | 761 | Q15111 | |
| NSEQLTRAQCVTVKE | 71 | Q9Y3V2 | |
| VEKSNQVCTSCEDNA | 156 | O15164 | |
| NTAVIIACTTNNSEA | 166 | O75762 | |
| SKSSAVIEQGDCKNN | 1601 | Q8WWQ0 | |
| QDLVSSGISEQTKQC | 486 | A0A1B0GUW6 | |
| LQQCKAELNSTTEEL | 696 | O95235 | |
| VQSAKEVANSTANLV | 1526 | Q9Y490 | |
| NLKEGTICTESSQQE | 476 | Q8N5U6 | |
| GDLETVKQLCSSQNV | 661 | O95271 | |
| VAKLNQDNSETAEQC | 76 | Q6NX45 | |
| LRKGSSNNQDVVTCD | 451 | Q6NUQ4 | |
| CNSQVKETSEQEGAK | 2431 | O60281 | |
| TVSAATQTIKNVCEQ | 1166 | Q12888 | |
| NENSKVLVGNETCNV | 1181 | Q86WI1 | |
| QECQIQSCELSVAQK | 91 | Q1RN00 | |
| DEQASQVALENCSAV | 96 | Q93038 | |
| SSVVEAESNVTLKCQ | 36 | Q6UX27 | |
| LQGDVASCNTQVAEK | 581 | A0A1B0GTU1 | |
| NDIQETCQKNAASAL | 671 | Q6PJI9 | |
| KDNTIGVTVNCKDQA | 1031 | O15090 | |
| TIDNLCSIKLDNSNS | 466 | Q8NEG5 | |
| QGTDNSDQSEICKLQ | 201 | Q15643 | |
| VTEIDCAQDSKQNNL | 3911 | Q7Z7G8 | |
| GSVLIKENAQEVNTC | 451 | Q86YA3 | |
| CNASTELTTLKNIQD | 1536 | Q86YA3 | |
| AKNSNSNNTDIAECV | 151 | Q9UI33 | |
| NEVINESNSVSLSCI | 1226 | Q9BXT5 | |
| ESNSVSLSCIKENIN | 1231 | Q9BXT5 | |
| QDNDIVNSSIKNSSC | 2536 | Q9BXT5 | |
| SCSENLQVKLVSDGQ | 111 | Q16600 | |
| CQSIQDSQQVTEVSL | 526 | Q6NUS6 | |
| GKQAAASQITCENEL | 136 | Q9P2Z0 | |
| EQEENIQTCTKAIAS | 2321 | P31629 | |
| AINSQATNELSCEIT | 251 | Q6N021 | |
| IELQTKRAECDSANN | 511 | Q9NVE5 | |
| QVTCLACDNKSNTIE | 476 | Q9H0E7 | |
| QKSSQLCQKVSEEVC | 1311 | Q6PFW1 | |
| SCETKDLVVQQAGTN | 166 | P25942 | |
| TETATLCLDVDNKNN | 1086 | Q96C45 | |
| KQCSSLQTAIADAEQ | 386 | O95678 | |
| CQNSKLEAAVAQSEQ | 341 | Q14533 | |
| SKVAALQDQCADASI | 801 | Q9UPR5 | |
| KLVNSVSVNTDCVQQ | 826 | Q86UW6 | |
| TEDCQVQLTCKVTNT | 1131 | Q5VTT5 | |
| KQTSCQDGLSQDLNE | 856 | Q9ULJ8 |